BMPR1B
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A0MZ66 | S473 | Sugiyama | SHTN1 KIAA1598 | LGtLNKSTSSRsLKsLDPENsEtELERILRRRKVtAEADss |
| A5A3E0 | S1065 | Sugiyama | POTEF A26C1B | ILASLSTFQQMWISKQEyDEsGPsIVHRKCL__________ |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| O00170 | T48 | Sugiyama | AIP XAP2 | FQDGTKATFHYRtLHsDDEGtVLDDsRARGKPMELIIGKKF |
| O00238 | S497 | Sugiyama | BMPR1B | NPASRLTALRVKKTLAKMSEsQDIKL_______________ |
| O00299 | S156 | Sugiyama | CLIC1 G6 NCC27 | ALKVLDNyLTsPLPEEVDEtsAEDEGVsQRKFLDGNELTLA |
| O00505 | S60 | Sugiyama | KPNA3 QIP2 | KRDEHLLKKRNVPQEEsLEDsDVDADFKAQNVTLEAILQNA |
| O15067 | S530 | Sugiyama | PFAS KIAA0361 | PICsLHDQGAGGNGNVLKELsDPAGAIIytsRFQLGDPTLN |
| O15270 | T560 | Sugiyama | SPTLC2 KIAA0526 LCB2 | SRHRLVPLLDRPFDETTyEEtED__________________ |
| O43852 | S261 | Sugiyama | CALU | RDKNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNK |
| O60220 | S96 | Sugiyama | TIMM8A DDP DDP1 TIM8A | FILNRLEQTQKSKPVFSEsLsD___________________ |
| O60231 | S319 | Sugiyama | DHX16 DBP2 DDX16 KIAA0577 PRP2 | HMPKETRGQPARAVDLVEEEsGAPGEEQRRWEEARLGAASL |
| O60664 | S148 | Sugiyama | PLIN3 M6PRBP1 TIP47 | KVsGAQEMVssAKDTVAtQLsEAVDATRGAVQSGVDKTKsV |
| O60664 | S93 | Sugiyama | PLIN3 M6PRBP1 TIP47 | AAVsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQP |
| O60841 | S66 | Sugiyama | EIF5B IF2 KIAA0741 | KEKKKQDFDEDDILKELEELsLEAQGIKADREtVAVKPTEN |
| O60927 | S74 | Sugiyama | PPP1R11 HCGV TCTE5 | GRRssKCCCIyEKPRAFGEsstEsDEEEEEGCGHtHCVRGH |
| O75400 | S938 | Sugiyama | PRPF40A FBP11 FLAF1 FNBP3 HIP10 HYPA HSPC225 | SPKKKtGKDsGNWDtsGsELsEGELEKRRRtLLEQLDDDQ_ |
| O75534 | S74 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | SQYNGNLQDLKVGDDVEFEVsSDRRTGKPIAVKLVKIKQEI |
| O75821 | S189 | Sugiyama | EIF3G EIF3S4 | CPYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNK |
| O75821 | S28 | Sugiyama | EIF3G EIF3S4 | sKPsWADQVEEEGEDDKCVtsELLKGIPLAtGDtsPEPELL |
| O75821 | T27 | Sugiyama | EIF3G EIF3S4 | DsKPsWADQVEEEGEDDKCVtsELLKGIPLAtGDtsPEPEL |
| O95218 | S188 | Sugiyama | ZRANB2 ZIS ZNF265 | KLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRRSRSKSRS |
| O95630 | S2 | SIGNOR|iPTMNet | STAMBP AMSH | ___________________MsDHGDVSLPPEDRVRALSQLG |
| O95630 | S243 | SIGNOR|iPTMNet | STAMBP AMSH | TTVRPAKPPVVDRSLKPGALsNsEsIPTIDGLRHVVVPGRL |
| O95630 | S245 | SIGNOR|iPTMNet | STAMBP AMSH | VRPAKPPVVDRSLKPGALsNsEsIPTIDGLRHVVVPGRLCP |
| O95630 | S247 | SIGNOR|iPTMNet | STAMBP AMSH | PAKPPVVDRSLKPGALsNsEsIPTIDGLRHVVVPGRLCPQF |
| O95630 | S48 | SIGNOR|iPTMNet | STAMBP AMSH | NEDIPPRRYFRSGVEIIRMAsIYSEEGNIEHAFILYNKYIT |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00558 | S393 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDA |
| P00558 | T394 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDAL |
| P04040 | T28 | Sugiyama | CAT | ASDQMQHWKEQRAAQKADVLttGAGNPVGDKLNVItVGPRG |
| P04075 | S132 | Sugiyama | ALDOA ALDA | GVVPLAGtNGEtttQGLDGLsERCAQYKKDGADFAKWRCVL |
| P04075 | S17 | Sugiyama | ALDOA ALDA | ____MPyQyPALtPEQKKELsDIAHRIVAPGKGILAADEst |
| P04075 | S354 | Sugiyama | ALDOA ALDA | ANsLACQGKytPsGQAGAAAsEsLFVsNHAy__________ |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T124 | Sugiyama | ALDOA ALDA | VVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYKKDGAD |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | S189 | Sugiyama | ANXA1 ANX1 LPC1 | tsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsDARALyEA |
| P04083 | S201 | Sugiyama | ANXA1 ANX1 LPC1 | LsLAKGDRsEDFGVNEDLADsDARALyEAGERRKGtDVNVF |
| P04083 | T169 | Sugiyama | ANXA1 ANX1 LPC1 | IRDINRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRs |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05388 | S304 | Sugiyama | RPLP0 | AttAAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD_______ |
| P05388 | S307 | Sugiyama | RPLP0 | AAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD__________ |
| P05455 | S83 | Sugiyama | SSB | TDFNVIVEALSKSKAELMEIsEDKTKIRRsPsKPLPEVTDE |
| P05787 | S291 | Sugiyama | KRT8 CYK8 | ANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTEISEMN |
| P06733 | S40 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGK |
| P06733 | T100 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | KKLNVtEQEKIDKLMIEMDGtENKsKFGANAILGVsLAVCK |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | T18 | Sugiyama | LDHB | ___MATLKEKLIAPVAEEEAtVPNNKITVVGVGQVGMACAI |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | S393 | Sugiyama | PGK2 PGKB | GGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEA |
| P07205 | T394 | Sugiyama | PGK2 PGKB | GDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEAL |
| P07237 | S88 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GKLKAEGSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNG |
| P07237 | T335 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | VRLITLEEEMTKyKPEsEELtAERItEFCHRFLEGKIKPHL |
| P07237 | T85 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | KAAGKLKAEGSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFF |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07437 | S115 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | sGAGNNWAKGHytEGAELVDsVLDVVRKEAESCDCLQGFQL |
| P07437 | T107 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKEAESC |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07737 | S85 | Sugiyama | PFN1 | tLGGQKCsVIRDsLLQDGEFsMDLRtKstGGAPTFNVtVtK |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S231 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | SQFIGyPITLFVEKERDKEVsDDEAEEKEDKEEEKEKEEKE |
| P07900 | S263 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EEKEKEEKEsEDKPEIEDVGsDEEEEKKDGDKKKKKKIKEK |
| P07900 | S391 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MDNCEELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | T195 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DTGEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIG |
| P07900 | T305 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IDQEELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLA |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | T275 | Sugiyama | SLC3A2 MDU1 | KVKGLVLGPIHKNQKDDVAQtDLLQIDPNFGsKEDFDsLLQ |
| P08195 | T599 | Sugiyama | SLC3A2 MDU1 | QASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEPH |
| P08238 | S383 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MDSCDELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S470 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEs |
| P08238 | T190 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| P08238 | T297 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IDQEELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLA |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y472 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKE |
| P08708 | S89 | Sugiyama | RPS17 RPS17L | ISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKEMLKLL |
| P08758 | T10 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | ___________MAQVLRGtVtDFPGFDERADAEtLRKAMKG |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P09972 | S132 | Sugiyama | ALDOC ALDC | GVVPLAGtDGEtttQGLDGLsERCAQYKKDGADFAKWRCVL |
| P09972 | T125 | Sugiyama | ALDOC ALDC | VGIKVDKGVVPLAGtDGEtttQGLDGLsERCAQYKKDGADF |
| P0CG38 | S1065 | Sugiyama | POTEI | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P0CG39 | S1028 | Sugiyama | POTEJ | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P10809 | S67 | Sugiyama | HSPD1 HSP60 | LADAVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLK |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11586 | T128 | Sugiyama | MTHFD1 MTHFC MTHFD | SINTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCt |
| P12004 | S261 | Sugiyama | PCNA | IADMGHLKyyLAPKIEDEEGs____________________ |
| P12956 | S27 | Sugiyama | XRCC6 G22P1 | YYKtEGDEEAEEEQEENLEAsGDyKYsGRDsLIFLVDASKA |
| P13489 | S290 | Sugiyama | RNH1 PRI RNH | AKGCGDLCRVLRAKESLKELsLAGNELGDEGARLLCETLLE |
| P13489 | T176 | Sugiyama | RNH1 PRI RNH | AASCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKD |
| P13639 | S584 | Sugiyama | EEF2 EF2 | DHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyM |
| P13639 | S587 | Sugiyama | EEF2 EF2 | CIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKAR |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P13667 | S379 | Sugiyama | PDIA4 ERP70 ERP72 | QPEKFQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGH |
| P13667 | S468 | Sugiyama | PDIA4 ERP70 ERP72 | ytFAIADEEDyAGEVKDLGLsEsGEDVNAAILDEsGKKFAM |
| P13667 | S470 | Sugiyama | PDIA4 ERP70 ERP72 | FAIADEEDyAGEVKDLGLsEsGEDVNAAILDEsGKKFAMEP |
| P14618 | S287 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | IIsKIENHEGVRRFDEILEAsDGIMVARGDLGIEIPAEKVF |
| P14618 | S346 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | CAtQMLEsMIKKPRPTRAEGsDVANAVLDGADCIMLSGEtA |
| P14625 | S439 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | TDDFHDMMPKyLNFVKGVVDsDDLPLNVsREtLQQHKLLKV |
| P14625 | T522 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | NRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMA |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P15531 | S120 | Sugiyama | NME1 NDPKA NM23 | KPGtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELV |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P17987 | S551 | Sugiyama | TCP1 CCT1 CCTA | IKLHPESKDDKHGsyEDAVHsGALND_______________ |
| P18206 | S726 | Sugiyama | VCL | VEKMTGLVDEAIDtKsLLDAsEEAIKKDLDKCKVAMANIQP |
| P18669 | T146 | Sugiyama | PGAM1 PGAMA CDABP0006 | MEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIARALPF |
| P20810 | S373 | Sugiyama | CAST | LPEPEEKPKPRsEsELIDELsEDFDRsECKEKPSKPTEKTE |
| P21291 | S192 | Sugiyama | CSRP1 CSRP CYRP | AKNFGPKGFGFGQGAGALVHsE___________________ |
| P22314 | S46 | Sugiyama | UBA1 A1S9T UBE1 | AQsVLsEVPSVPTNGMAKNGsEADIDEGLysRQLyVLGHEA |
| P23396 | T242 | Sugiyama | RPS3 OK/SW-cl.26 | PIsEQKGGKPEPPAMPQPVPtA___________________ |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P25788 | S250 | Sugiyama | PSMA3 HC8 PSC8 | KDIREEAEKyAKEsLKEEDEsDDDNM_______________ |
| P26038 | S527 | Sugiyama | MSN | ERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHAE |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26639 | S39 | Sugiyama | TARS1 TARS | PIGAGEEKQKEGGKKKNKEGsGDGGRAELNPWPEyIytRLE |
| P27348 | S145 | Sugiyama | YWHAQ | YFRyLAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHP |
| P27348 | S37 | Sugiyama | YWHAQ | ERyDDMAtCMKAVtEQGAELsNEERNLLsVAyKNVVGGRRS |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27695 | T19 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | __MPKRGKKGAVAEDGDELRtEPEAKKSKTAAKKNDKEAAG |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27816 | S643 | Sugiyama | MAP4 | IsPEtVTGtGKKCsLPAEEDsVLEKLGERKPCNsQPSELSS |
| P28066 | S174 | Sugiyama | PSMA5 | FHMDPsGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEA |
| P28066 | S179 | Sugiyama | PSMA5 | sGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEAIKSSL |
| P29401 | S190 | Sugiyama | TKT | ASIYKLDNLVAILDINRLGQsDPAPLQHQMDIyQKRCEAFG |
| P29401 | S295 | Sugiyama | TKT | ysQIQsKKKILAtPPQEDAPsVDIANIRMPsLPsyKVGDKI |
| P29401 | T454 | Sugiyama | TKT | LAMFRsVPtstVFyPsDGVAtEKAVELAANTKGICFIRTsR |
| P29692 | S70 | Sugiyama | EEF1D EF1D | IARARENIQKsLAGssGPGAssGtsGDHGELVVRIAsLEVE |
| P30041 | T49 | Sugiyama | PRDX6 AOP2 KIAA0106 | LGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKRNVKLI |
| P30043 | T199 | Sugiyama | BLVRB FLR SCAN | HDLGHFMLRCLttDEyDGHstyPsHQyQ_____________ |
| P30048 | S86 | Sugiyama | PRDX3 AOP1 | TQHAPYFKGTAVVNGEFKDLsLDDFKGKYLVLFFYPLDFTF |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P31943 | S63 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | IRFIYTREGRPsGEAFVELEsEDEVKLALKKDRETMGHRyV |
| P31946 | S39 | Sugiyama | YWHAB | ERyDDMAAAMKAVtEQGHELsNEERNLLsVAyKNVVGARRS |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S37 | Sugiyama | SFN HME1 | ERyEDMAAFMKGAVEKGEELsCEERNLLsVAyKNVVGGQRA |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P34932 | S31 | Sugiyama | HSPA4 APG2 HSPH2 | QSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGAA |
| P34932 | S414 | Sugiyama | HSPA4 APG2 HSPH2 | ITDVVPYPISLRWNsPAEEGssDCEVFSKNHAAPFSKVLTF |
| P35269 | S217 | Sugiyama | GTF2F1 RAP74 | RGRRKASELRIHDLEDDLEMssDAsDAsGEEGGRVPKAKKK |
| P35579 | S1943 | Sugiyama | MYH9 | RGDLPFVVPRRMARKGAGDGsDEEVDGKADGAEAKPAE___ |
| P35579 | T1745 | Sugiyama | MYH9 | RRLEARIAQLEEELEEEQGNtELINDRLKKANLQIDQINtD |
| P35579 | T1904 | Sugiyama | MYH9 | EEAQRANAsRRKLQRELEDAtEtADAMNREVssLKNKLRRG |
| P35580 | T1911 | Sugiyama | MYH10 | EEATRANASRRKLQRELDDAtEANEGLSREVSTLKNRLRRG |
| P35659 | S231 | Sugiyama | DEK | SGMARKAKRTKCPEILsDEsssDEDEKKNKEEssDDEDKEs |
| P36871 | S477 | Sugiyama | PGM1 | KQFSANDKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTDG |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P41091 | T21 | Sugiyama | EIF2S3 EIF2G | MAGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAt |
| P41227 | S216 | Sugiyama | NAA10 ARD1 ARD1A TE2 | EEKGLAAEDsGGDsKDLsEVsEtTEstDVKDssEAsDsAs_ |
| P43121 | T298 | Sugiyama | MCAM MUC18 | PPPHFSISKQNPstREAEEEttNDNGVLVLEPARKEHSGRY |
| P43121 | T299 | Sugiyama | MCAM MUC18 | PPHFSISKQNPstREAEEEttNDNGVLVLEPARKEHSGRYE |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P48643 | S270 | Sugiyama | CCT5 CCTE KIAA0098 | ILTCPFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQ |
| P48643 | T269 | Sugiyama | CCT5 CCTE KIAA0098 | AILTCPFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMI |
| P49327 | S1129 | Sugiyama | FASN FAS | QQVPILEKFCFtPHTEEGCLsERAALQEELQLCKGLVQALQ |
| P49327 | S2198 | Sugiyama | FASN FAS | EVRQLTLRKLQELSSKADEAsELACPtPKEDGLAQQQtQLN |
| P49588 | T481 | Sugiyama | AARS1 AARS | DLIMLDIYAIEELRARGLEVtDDsPKYNYHLDSSGSYVFEN |
| P51003 | S672 | Sugiyama | PAPOLA PAP | tssPHKEEsPKKTKTEEDETsEDANCLALsGHDKTEAKEQL |
| P52597 | S107 | Sugiyama | HNRNPF HNRPF | KSHRTEMDWVLKHsGPNsADsANDGFVRLRGLPFGCTKEEI |
| P52907 | S106 | Sugiyama | CAPZA1 | RFLDPRNKISFKFDHLRKEAsDPQPEEADGGLKsWREsCDs |
| P53675 | S460 | Sugiyama | CLTCL1 CLH22 CLTCL CLTD | LQQGRKQLLEKWLKEDKLECsEELGDLVKTTDPMLALSVYL |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P53999 | S19 | Sugiyama | SUB1 PC4 RPO2TC1 | __MPKSKELVsssssGsDsDsEVDKKLKRKKQVAPEKPVKK |
| P54578 | S492 | Sugiyama | USP14 TGT | WHIAYVLLYGPRRVEIMEEEsEQ__________________ |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P55060 | S366 | Sugiyama | CSE1L CAS XPO2 | KVIVPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAA |
| P57721 | S82 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | GKKGETVKKMREESGARINIsEGNCPERIVTITGPTDAIFK |
| P58546 | T108 | Sugiyama | MTPN | LSKGADKTVKGPDGLTAFEAtDNQAIKALLQ__________ |
| P60174 | T38 | Sugiyama | TPI1 TPI | RKQsLGELIGtLNAAKVPADtEVVCAPPtAyIDFARQKLDP |
| P60709 | S365 | Sugiyama | ACTB | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P60709 | T106 | Sugiyama | ACTB | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P61221 | S218 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | AIVCQQLDLTHLKERNVEDLsGGELQRFACAVVCIQKADIF |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P61981 | S38 | Sugiyama | YWHAG | ERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKNVVGARRS |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62269 | T60 | Sugiyama | RPS18 D6S218E | YAHVVLRKADIDLTKRAGELtEDEVERVItIMQNPRQYKIP |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62826 | S150 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLARKLIG |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P63104 | S145 | Sugiyama | YWHAZ | YYRyLAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHP |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | S37 | Sugiyama | YWHAZ | ERyDDMAACMKsVtEQGAELsNEERNLLsVAyKNVVGARRs |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63151 | S409 | Sugiyama | PPP2R2A | RTVLKPRKVCASGKRKKDEIsVDsLDFNKKILHTAWHPKEN |
| P63167 | S14 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | _______MCDRKAVIKNADMsEEMQQDsVECAtQALEKYNI |
| P63261 | S365 | Sugiyama | ACTG1 ACTG | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P63261 | T106 | Sugiyama | ACTG1 ACTG | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | S439 | Sugiyama | TUBA1B | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P78371 | S150 | Sugiyama | CCT2 99D8.1 CCTB | WREATKAAREALLssAVDHGsDEVKFRQDLMNIAGTTLssK |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| Q00341 | S35 | Sugiyama | HDLBP HBP VGL | HRSGLVPQQIKVAtLNsEEEsDPPtyKDAFPPLPEKAACLE |
| Q00610 | S460 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | LQQGRKQLLEKWLKEDKLECsEELGDLVKSVDPTLALSVYL |
| Q01105 | S166 | Sugiyama | SET | yFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQT |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q04637 | S1430 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | GQDIGAFVAEQKVEyTLGEEsEAPGQRALPsEELNRQLEKL |
| Q04917 | S150 | Sugiyama | YWHAH YWHA1 | YYRYLAEVASGEKKNsVVEAsEAAyKEAFEISKEQMQPTHP |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q06830 | S152 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | IIDDKGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEV |
| Q08J23 | T733 | Sugiyama | NSUN2 SAKI TRM4 | EGVILtNEsAAstGQPDNDVtEGQRAGEPNsPDAEEANsPD |
| Q12792 | T348 | Sugiyama | TWF1 PTK9 | GPAGKRGIRRLIRGPAEtEAttD__________________ |
| Q12792 | T349 | Sugiyama | TWF1 PTK9 | PAGKRGIRRLIRGPAEtEAttD___________________ |
| Q12874 | S482 | Sugiyama | SF3A3 SAP61 | LKLQKASERWQPDtEEEyEDssGNVVNKKTYEDLKRQGLL_ |
| Q12874 | S483 | Sugiyama | SF3A3 SAP61 | KLQKASERWQPDtEEEyEDssGNVVNKKTYEDLKRQGLL__ |
| Q12906 | T300 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | ASGIVMPDGSGIYDPCEKEAtDAIGHLDRQQREDItQsAQH |
| Q13283 | T241 | Sugiyama | G3BP1 G3BP | ETAPEDAQKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPP |
| Q13371 | S25 | Sugiyama | PDCL PHLOP1 PhLP1 | DDKLLGEKLQyyysssEDEDsDHEDKDRGRCAPAsssVPAE |
| Q13428 | S765 | Sugiyama | TCOF1 | GKTGPTVTQVKAEKQEDsEssEEEsDSEEAAAsPAQVKTSV |
| Q13442 | S63 | Sugiyama | PDAP1 HASPP28 | GGDGAAGDPKKEKKsLDsDEsEDEEDDyQQKRKGVEGLIDI |
| Q13509 | S115 | Sugiyama | TUBB3 TUBB4 | SGAGNNWAKGHytEGAELVDsVLDVVRKECENCDCLQGFQL |
| Q13509 | T107 | Sugiyama | TUBB3 TUBB4 | PDNFIFGQSGAGNNWAKGHytEGAELVDsVLDVVRKECENC |
| Q13541 | S112 | Sugiyama | EIF4EBP1 | EAsQsHLRNsPEDKRAGGEEsQFEMDI______________ |
| Q13547 | S421 | Sugiyama | HDAC1 RPD3L1 | PDKRIsICssDKRIACEEEFsDsEEEGEGGRKNsSNFKKAK |
| Q13561 | T114 | Sugiyama | DCTN2 DCTN50 | GVKETPQQKYQRLLHEVQELtTEVEKIKTTVKEsATEEKLt |
| Q13873 | S375 | Sugiyama | BMPR2 PPH1 | SMRLTGNRLVRPGEEDNAAIsEVGtIRYMAPEVLEGAVNLR |
| Q13873 | S681 | Sugiyama | BMPR2 PPH1 | EDLETNKLDPKEVDKNLKEssDENLMEHsLKQFSGPDPLSS |
| Q13873 | S689 | Sugiyama | BMPR2 PPH1 | DPKEVDKNLKEssDENLMEHsLKQFSGPDPLSSTSSSLLyP |
| Q13885 | S115 | Sugiyama | TUBB2A TUBB2 | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q13885 | T107 | Sugiyama | TUBB2A TUBB2 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q14152 | S1256 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EDRFRRPRDEGGWRRGPAEEsssWRDssRRDDRDRDDRRRE |
| Q14566 | T321 | Sugiyama | MCM6 | CCVAPTNPRFGGKELRDEEQtAEsIKNQMTVKEWEKVFEMs |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14978 | S90 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | ANGPVAKKAKKKAsssDsEDssEEEEEVQGPPAKKAAVPAK |
| Q14C86 | S576 | Sugiyama | GAPVD1 GAPEX5 KIAA1521 RAP6 | HGKPDKTLRFSLCsDNLEGIsEGPSNRSNSVSSLDLEGESV |
| Q15007 | S271 | Sugiyama | WTAP KIAA0105 | TSRTTASEPVEQSEATSKDCsRLtNGPsNGsssRQRtsGSG |
| Q15007 | S278 | Sugiyama | WTAP KIAA0105 | EPVEQSEATSKDCsRLtNGPsNGsssRQRtsGSGFHREGNt |
| Q15007 | S281 | Sugiyama | WTAP KIAA0105 | EQSEATSKDCsRLtNGPsNGsssRQRtsGSGFHREGNtTED |
| Q15007 | S282 | Sugiyama | WTAP KIAA0105 | QSEATSKDCsRLtNGPsNGsssRQRtsGSGFHREGNtTEDD |
| Q15007 | S283 | Sugiyama | WTAP KIAA0105 | SEATSKDCsRLtNGPsNGsssRQRtsGSGFHREGNtTEDDF |
| Q15007 | T274 | Sugiyama | WTAP KIAA0105 | TTASEPVEQSEATSKDCsRLtNGPsNGsssRQRtsGSGFHR |
| Q15084 | T166 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | YSSGKQGRSDsSSKKDVIELtDDsFDKNVLDSEDVWMVEFY |
| Q15293 | T100 | Sugiyama | RCN1 RCN | sKERLGKIVDRIDNDGDGFVttEELKtWIKRVQKRyIFDNV |
| Q15365 | S50 | Sugiyama | PCBP1 | GKKGESVKRIREEsGARINIsEGNCPERIItLTGPTNAIFK |
| Q15366 | S50 | Sugiyama | PCBP2 | GKKGESVKKMREESGARINIsEGNCPERIITLAGPTNAIFK |
| Q15796 | S464 | GPS6|ELM|iPTMNet|EPSD|PSP | SMAD2 MADH2 MADR2 | GPLQWLDKVLTQMGsPsVRCssMs_________________ |
| Q15796 | S465 | GPS6|ELM|iPTMNet|EPSD|PSP | SMAD2 MADH2 MADR2 | PLQWLDKVLTQMGsPsVRCssMs__________________ |
| Q15796 | S467 | GPS6|ELM|iPTMNet|EPSD|PSP | SMAD2 MADH2 MADR2 | QWLDKVLTQMGsPsVRCssMs____________________ |
| Q15797 | S462 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SMAD1 BSP1 MADH1 MADR1 | GPLQWLDKVLTQMGsPHNPIssVs_________________ |
| Q15797 | S463 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SMAD1 BSP1 MADH1 MADR1 | PLQWLDKVLTQMGsPHNPIssVs__________________ |
| Q15797 | S465 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | SMAD1 BSP1 MADH1 MADR1 | QWLDKVLTQMGsPHNPIssVs____________________ |
| Q16576 | T10 | Sugiyama | RBBP7 RBAP46 | ___________MAsKEMFEDtVEERVINEEYKIWKKNTPFL |
| Q2T9J0 | S171 | Sugiyama | TYSND1 | FGDEAAEQWRFSSAARDDEVsEDEEADQLRALGWFALLGVR |
| Q2VIR3 | T21 | Sugiyama | EIF2S3B | MAGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAt |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF6 | T165 | Sugiyama | HSP90AB4P | DHGEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIG |
| Q58FF7 | T169 | Sugiyama | HSP90AB3P HSP90BC | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| Q66LE6 | S415 | Sugiyama | PPP2R2D KIAA1541 | RASLKPRKVCTGGKRRKDEIsVDsLDFNKKILHTAWHPVDN |
| Q6NVY1 | T368 | Sugiyama | HIBCH | AVLIDKDQSPKWKPADLKEVtEEDLNNHFKSLGsSDLKF__ |
| Q6PKG0 | S631 | Sugiyama | LARP1 KIAA0731 LARP | EEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPH |
| Q6S8J3 | S1065 | Sugiyama | POTEE A26C1A POTE2 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6UXH1 | S295 | Sugiyama | CRELD2 UNQ185/PRO211 | KECISGYAREHGQCADVDECsLAEKtCVRKNENCYNTPGSY |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71U36 | S439 | Sugiyama | TUBA1A TUBA3 | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q7LDG7 | T4 | Sugiyama | RASGRP2 CDC25L MCG7 | _________________MAGtLDLDKGCTVEELLRGCIEAF |
| Q7Z460 | S246 | Sugiyama | CLASP1 KIAA0622 MAST1 | VQKSGNMIQSANDKNFDDEDsVDGNRPssAsStSSKAPPSS |
| Q86TG7 | S10 | Sugiyama | PEG10 EDR KIAA1051e MAR2 MART2 MEF3L1 RGAG3 | ___________MTERRRDELsEEINNLREKVMKQSEENNNL |
| Q8NBJ5 | S616 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | EQQALSREAKNsDVLQsPLDsAARDEL______________ |
| Q8NE71 | S595 | Sugiyama | ABCF1 ABC50 | TKEALTRKQQKCRRKNQDEEsQEAPELLKRPKEYTVRFTFP |
| Q8NHW5 | S304 | Sugiyama | RPLP0P6 | DTTAAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD_______ |
| Q8NHW5 | S307 | Sugiyama | RPLP0P6 | AAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD__________ |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TBF4 | S216 | Sugiyama | ZCRB1 | DDSRRPRIKKstYFsDEEELsD___________________ |
| Q8WUM4 | T464 | Sugiyama | PDCD6IP AIP1 ALIX KIAA1375 | LQRNREILDEsLRLLDEEEAtDNDLRAKFKERWQRtPSNEL |
| Q92769 | S422 | Sugiyama | HDAC2 | PDKRIsIRAsDKRIACDEEFsDsEDEGEGGRRNVADHKKGA |
| Q92890 | T210 | Sugiyama | UFD1 UFD1L | DFDAPLGYKEPERQVQHEEstEGEADHsGyAGELGFRAFsG |
| Q96A49 | S313 | Sugiyama | SYAP1 PRO3113 | EMEQLVLDKKQEEtAVLEEDsADWEKELQQELQEyEVVtES |
| Q96A49 | T306 | Sugiyama | SYAP1 PRO3113 | NQEDLRKEMEQLVLDKKQEEtAVLEEDsADWEKELQQELQE |
| Q96D46 | T470 | Sugiyama | NMD3 CGI-07 | EAIRKNVNIyRDsAIPVEsDtDDEGAPRISLAEMLEDLHIs |
| Q96HE7 | S143 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | EANNLIEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSD |
| Q96HE7 | S145 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | NNLIEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSDNF |
| Q96HE7 | T148 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | IEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSDNFCEA |
| Q96IR7 | S365 | Sugiyama | HPDL GLOXD1 | GATGFGQGNIRALWQsVQEQsARSQEA______________ |
| Q96QK1 | T763 | Sugiyama | VPS35 MEM3 TCCCTA00141 | LNQLIQKIREDLPNLEssEEtEQINKHFHNtLEHLRLRREs |
| Q99497 | S57 | Sugiyama | PARK7 | GLAGKDPVQCsRDVVICPDAsLEDAKKEGPyDVVVLPGGNL |
| Q99613 | S39 | Sugiyama | EIF3C EIF3S8 | GEELVTKPVGGNyGKQPLLLsEDEEDTKRVVRSAKDKRFEE |
| Q99614 | S90 | Sugiyama | TTC1 TPR1 | FEEEPGADKVENKsNEDVNssELDEEyLIELEKNMSDEEKQ |
| Q99733 | S121 | Sugiyama | NAP1L4 NAP2 | PLFDKRREFItGDVEPtDAEsEWHsENEEEEKLAGDMKSKV |
| Q99733 | T117 | Sugiyama | NAP1L4 NAP2 | ALyQPLFDKRREFItGDVEPtDAEsEWHsENEEEEKLAGDM |
| Q99832 | T351 | Sugiyama | CCT7 CCTH NIP7-1 | QtSVNALSADVLGRCQVFEEtQIGGERyNFFtGCPKAKTCt |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BVA1 | S115 | Sugiyama | TUBB2B | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q9BVA1 | T107 | Sugiyama | TUBB2B | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q9BW91 | S343 | Sugiyama | NUDT9 NUDT10 PSEC0099 UNQ3012/PRO9771 | SHSQFIKLVAEKRDAHWSEDsEADCHAL_____________ |
| Q9BYX7 | S365 | Sugiyama | POTEKP ACTBL3 FKSG30 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9C0C2 | S804 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | EGSTREWASRCGIGQEEMEAsSsQDQSKVSAPGVLTAQDRV |
| Q9C0C2 | S806 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | STREWASRCGIGQEEMEAsSsQDQSKVSAPGVLTAQDRVVG |
| Q9C0C2 | T1323 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | ELGVGQMDWGNNLGLRDLEVtCDPDsGGsQGLRGCGVGQMD |
| Q9HCC0 | S256 | Sugiyama | MCCC2 MCCB | QGTIFLAGPPLVKAATGEEVsAEDLGGADLHCRKSGVSDHW |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NR28 | S230 | Sugiyama | DIABLO SMAC | EAQIEELRQKTQEEGEERAEsEQEAyLRED___________ |
| Q9UHX1 | S558 | Sugiyama | PUF60 FIR ROBPI SIAHBP1 | AGRKVVAEVYDQERFDNsDLsA___________________ |
| Q9UI30 | S125 | Sugiyama | TRMT112 AD-001 HSPC152 HSPC170 | RMFPISRGIPNMLLsEEEtEs____________________ |
| Q9UKK9 | S24 | Sugiyama | NUDT5 NUDIX5 HSPC115 | QEPtEssQNGKQyIISEELIsEGKWVKLEKTTYMDPTGKtR |
| Q9UNF1 | S52 | Sugiyama | MAGED2 BCG1 | TVTQNVEVPEtPKASKALEVsEDVKVSKASGVSKAtEVsKt |
| Q9UPR3 | S475 | Sugiyama | SMG5 EST1B KIAA1089 | RLSCLRRRRHPPKVGDDSDLsEGFEsDSSHDSARASEGSDS |
| Q9Y265 | S434 | Sugiyama | RUVBL1 INO80H NMP238 TIP49 TIP49A | NLLAKINGKDSIEKEHVEEIsELFyDAKSSAKILADQQDKY |
| Q9Y2B0 | S116 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | IDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKFA |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2T7 | T143 | Sugiyama | YBX2 CSDA3 MSY2 | QtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEATNVTGP |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y4L1 | S763 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | LEAFIFEtQDKLyQPEyQEVsTEEQREEISGKLSAASTWLE |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y5S9 | Y54 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KRKGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWI |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin organization | R-HSA-4839726 | 5.630715e-10 | 9.249 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.452498e-09 | 8.838 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.728849e-07 | 6.762 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.781315e-07 | 6.749 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.098241e-06 | 5.959 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.079898e-06 | 5.682 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.227591e-06 | 5.491 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 9.314025e-06 | 5.031 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.603276e-05 | 4.584 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.674627e-05 | 4.573 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.775485e-05 | 4.423 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 4.168880e-05 | 4.380 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 5.626502e-05 | 4.250 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 6.720386e-05 | 4.173 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.059961e-05 | 4.094 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 8.991614e-05 | 4.046 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.797109e-04 | 3.745 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.903560e-04 | 3.720 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.903560e-04 | 3.720 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.903756e-04 | 3.720 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.318101e-04 | 3.635 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.053314e-04 | 3.515 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.086490e-04 | 3.511 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.303270e-04 | 3.481 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.052109e-04 | 3.392 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.899218e-04 | 3.229 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 7.500635e-04 | 3.125 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 7.500635e-04 | 3.125 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 7.500635e-04 | 3.125 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 9.102935e-04 | 3.041 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.102662e-03 | 2.958 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.235227e-03 | 2.908 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.324806e-03 | 2.878 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.404626e-03 | 2.852 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.495099e-03 | 2.825 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.687160e-03 | 2.773 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.731060e-03 | 2.762 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.744261e-03 | 2.758 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.744261e-03 | 2.758 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.808202e-03 | 2.743 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.871741e-03 | 2.728 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.039275e-03 | 2.691 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.274951e-03 | 2.643 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.311822e-03 | 2.636 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.598554e-03 | 2.585 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.601129e-03 | 2.585 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.691764e-03 | 2.570 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.058513e-03 | 2.514 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.065343e-03 | 2.514 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 3.197393e-03 | 2.495 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.253070e-03 | 2.488 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.305949e-03 | 2.481 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.439416e-03 | 2.464 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.795864e-03 | 2.421 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.894027e-03 | 2.410 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.779153e-03 | 2.423 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.928821e-03 | 2.406 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.006609e-03 | 2.397 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.167441e-03 | 2.380 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.488740e-03 | 2.348 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.920560e-03 | 2.308 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.964416e-03 | 2.304 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 5.204439e-03 | 2.284 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 5.204439e-03 | 2.284 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 5.500391e-03 | 2.260 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.813151e-03 | 2.236 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.771160e-03 | 2.239 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 6.774335e-03 | 2.169 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 7.128401e-03 | 2.147 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 7.725154e-03 | 2.112 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 7.725154e-03 | 2.112 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 7.725154e-03 | 2.112 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 8.766364e-03 | 2.057 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 8.844254e-03 | 2.053 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 9.468097e-03 | 2.024 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 9.468097e-03 | 2.024 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.151327e-03 | 2.039 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 9.531133e-03 | 2.021 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 9.899871e-03 | 2.004 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 9.899871e-03 | 2.004 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.100968e-02 | 1.958 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.131011e-02 | 1.947 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.164527e-02 | 1.934 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.189260e-02 | 1.925 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.264921e-02 | 1.898 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.226134e-02 | 1.911 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.475524e-02 | 1.831 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.475524e-02 | 1.831 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.475524e-02 | 1.831 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.475524e-02 | 1.831 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.475524e-02 | 1.831 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.475524e-02 | 1.831 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.475524e-02 | 1.831 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.475524e-02 | 1.831 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.475524e-02 | 1.831 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.475524e-02 | 1.831 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.475524e-02 | 1.831 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.298298e-02 | 1.887 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.450758e-02 | 1.838 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.377930e-02 | 1.861 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.450710e-02 | 1.838 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.483310e-02 | 1.829 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.595088e-02 | 1.797 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.724110e-02 | 1.763 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.724110e-02 | 1.763 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.724110e-02 | 1.763 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.724110e-02 | 1.763 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.654351e-02 | 1.781 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.705056e-02 | 1.768 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.724110e-02 | 1.763 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.878411e-02 | 1.726 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.878411e-02 | 1.726 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.914469e-02 | 1.718 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.914469e-02 | 1.718 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.803803e-02 | 1.744 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.891250e-02 | 1.723 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.891250e-02 | 1.723 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.908831e-02 | 1.719 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.848254e-02 | 1.733 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.931896e-02 | 1.714 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.954365e-02 | 1.709 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.957640e-02 | 1.708 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.957640e-02 | 1.708 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.981466e-02 | 1.703 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.991199e-02 | 1.701 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.992956e-02 | 1.701 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.229681e-02 | 1.652 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.229681e-02 | 1.652 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.229681e-02 | 1.652 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.229681e-02 | 1.652 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.108728e-02 | 1.676 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.084684e-02 | 1.681 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.050933e-02 | 1.688 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.210879e-02 | 1.655 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.296582e-02 | 1.639 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.296711e-02 | 1.639 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.311307e-02 | 1.636 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.311307e-02 | 1.636 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.327377e-02 | 1.633 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 2.629217e-02 | 1.580 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 2.597127e-02 | 1.586 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.667434e-02 | 1.574 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.588872e-02 | 1.587 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.632129e-02 | 1.580 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.540103e-02 | 1.595 | 0 | 0 |
| SDK interactions | R-HSA-373756 | 2.697840e-02 | 1.569 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.697840e-02 | 1.569 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.697840e-02 | 1.569 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.844109e-02 | 1.546 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.799137e-02 | 1.553 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.897782e-02 | 1.538 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.923082e-02 | 1.534 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.878635e-02 | 1.541 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.811418e-02 | 1.551 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.897782e-02 | 1.538 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.846161e-02 | 1.546 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.787364e-02 | 1.555 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.061542e-02 | 1.514 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.788265e-02 | 1.555 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.962979e-02 | 1.528 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.078789e-02 | 1.512 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.125101e-02 | 1.505 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.253623e-02 | 1.488 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.254620e-02 | 1.487 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.288950e-02 | 1.483 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.333172e-02 | 1.477 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.349231e-02 | 1.475 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 3.403578e-02 | 1.468 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.403578e-02 | 1.468 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.435290e-02 | 1.464 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.435290e-02 | 1.464 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.492832e-02 | 1.457 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.492832e-02 | 1.457 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.939361e-02 | 1.405 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.939361e-02 | 1.405 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.644165e-02 | 1.438 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.934436e-02 | 1.405 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.759060e-02 | 1.425 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.932511e-02 | 1.405 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.847679e-02 | 1.415 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.816323e-02 | 1.418 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 3.859404e-02 | 1.413 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.970977e-02 | 1.401 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.014325e-02 | 1.396 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 4.147673e-02 | 1.382 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.147673e-02 | 1.382 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.147673e-02 | 1.382 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.151548e-02 | 1.382 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.188085e-02 | 1.378 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.188085e-02 | 1.378 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.188085e-02 | 1.378 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.188085e-02 | 1.378 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 4.219303e-02 | 1.375 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 4.219303e-02 | 1.375 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.324401e-02 | 1.364 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 4.360636e-02 | 1.360 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.433142e-02 | 1.353 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.489595e-02 | 1.348 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 5.240310e-02 | 1.281 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.852536e-02 | 1.314 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.852536e-02 | 1.314 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.943316e-02 | 1.306 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.943316e-02 | 1.306 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.741152e-02 | 1.324 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.185444e-02 | 1.285 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.247130e-02 | 1.280 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.245923e-02 | 1.280 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.095956e-02 | 1.293 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 5.337006e-02 | 1.273 | 0 | 0 |
| S Phase | R-HSA-69242 | 5.432596e-02 | 1.265 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.438462e-02 | 1.265 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.545554e-02 | 1.256 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 5.642668e-02 | 1.249 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.642668e-02 | 1.249 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.657971e-02 | 1.247 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.661650e-02 | 1.247 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.685638e-02 | 1.245 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 6.016845e-02 | 1.221 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 6.670979e-02 | 1.176 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 6.670979e-02 | 1.176 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 6.303476e-02 | 1.200 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.832470e-02 | 1.234 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 6.299695e-02 | 1.201 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 6.733329e-02 | 1.172 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 6.281213e-02 | 1.202 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 6.030019e-02 | 1.220 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.299695e-02 | 1.201 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.016845e-02 | 1.221 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.832470e-02 | 1.234 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.504560e-02 | 1.187 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 6.299695e-02 | 1.201 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 6.267530e-02 | 1.203 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 6.670979e-02 | 1.176 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.145898e-02 | 1.211 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.299695e-02 | 1.201 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 6.733329e-02 | 1.172 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.690170e-02 | 1.175 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 5.832470e-02 | 1.234 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 6.746833e-02 | 1.171 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 6.746833e-02 | 1.171 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 6.746833e-02 | 1.171 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 6.746833e-02 | 1.171 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 6.746833e-02 | 1.171 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.785026e-02 | 1.168 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 6.785026e-02 | 1.168 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.785026e-02 | 1.168 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 7.020654e-02 | 1.154 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 7.020654e-02 | 1.154 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.027519e-02 | 1.153 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.027519e-02 | 1.153 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 7.102491e-02 | 1.149 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 7.115928e-02 | 1.148 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 7.159672e-02 | 1.145 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.383075e-02 | 1.132 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 7.438517e-02 | 1.129 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 7.438517e-02 | 1.129 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 7.526445e-02 | 1.123 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 7.771298e-02 | 1.110 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 9.170508e-02 | 1.038 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 8.210391e-02 | 1.086 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 8.210391e-02 | 1.086 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 8.452205e-02 | 1.073 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.452205e-02 | 1.073 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 8.953497e-02 | 1.048 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.010642e-02 | 1.045 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 8.800651e-02 | 1.055 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.132385e-02 | 1.039 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 8.424379e-02 | 1.074 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 8.452205e-02 | 1.073 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 9.421307e-02 | 1.026 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 9.010642e-02 | 1.045 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.331923e-02 | 1.079 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.936636e-02 | 1.049 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 9.010642e-02 | 1.045 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 8.715541e-02 | 1.060 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 8.953497e-02 | 1.048 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 8.157631e-02 | 1.088 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.914001e-02 | 1.102 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.045754e-02 | 1.094 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 8.452205e-02 | 1.073 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 8.083285e-02 | 1.092 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 8.682103e-02 | 1.061 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 9.523405e-02 | 1.021 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 9.559287e-02 | 1.020 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 9.559287e-02 | 1.020 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 9.568986e-02 | 1.019 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 9.701811e-02 | 1.013 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 9.701811e-02 | 1.013 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 9.799756e-02 | 1.009 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.799756e-02 | 1.009 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 9.890282e-02 | 1.005 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 9.941129e-02 | 1.003 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 9.941129e-02 | 1.003 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.001055e-01 | 1.000 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.003232e-01 | 0.999 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.003232e-01 | 0.999 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.013638e-01 | 0.994 | 1 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.016811e-01 | 0.993 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.016811e-01 | 0.993 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.031899e-01 | 0.986 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.036763e-01 | 0.984 | 1 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.069402e-01 | 0.971 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.073131e-01 | 0.969 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.100775e-01 | 0.958 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.102216e-01 | 0.958 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.186088e-01 | 0.926 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.186088e-01 | 0.926 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.186088e-01 | 0.926 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.186088e-01 | 0.926 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.186088e-01 | 0.926 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.186088e-01 | 0.926 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.186088e-01 | 0.926 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.322753e-01 | 0.879 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.322753e-01 | 0.879 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 1.342885e-01 | 0.872 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.342885e-01 | 0.872 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 1.303953e-01 | 0.885 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.284928e-01 | 0.891 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.383864e-01 | 0.859 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.392723e-01 | 0.856 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.299282e-01 | 0.886 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.389355e-01 | 0.857 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.284928e-01 | 0.891 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.241426e-01 | 0.906 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.146753e-01 | 0.941 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.342885e-01 | 0.872 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 1.241426e-01 | 0.906 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 1.148615e-01 | 0.940 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.330894e-01 | 0.876 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.332325e-01 | 0.875 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.409662e-01 | 0.851 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.146753e-01 | 0.941 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.170807e-01 | 0.932 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.343124e-01 | 0.872 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.137293e-01 | 0.944 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.300787e-01 | 0.886 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.322753e-01 | 0.879 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 1.342885e-01 | 0.872 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.148615e-01 | 0.940 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.134569e-01 | 0.945 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.241426e-01 | 0.906 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 1.148615e-01 | 0.940 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.332325e-01 | 0.875 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.423913e-01 | 0.847 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.456916e-01 | 0.837 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.456916e-01 | 0.837 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.231556e-01 | 0.651 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.231556e-01 | 0.651 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.231556e-01 | 0.651 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.231556e-01 | 0.651 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.231556e-01 | 0.651 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.231556e-01 | 0.651 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.231556e-01 | 0.651 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.231556e-01 | 0.651 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.760023e-01 | 0.754 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.760023e-01 | 0.754 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 1.760023e-01 | 0.754 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 3.153069e-01 | 0.501 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.153069e-01 | 0.501 | 0 | 0 |
| Defective TPMT causes TPMT deficiency | R-HSA-5578995 | 3.153069e-01 | 0.501 | 0 | 0 |
| Defective SLC17A5 causes Salla disease (SD) and ISSD | R-HSA-5619035 | 3.153069e-01 | 0.501 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.153069e-01 | 0.501 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.153069e-01 | 0.501 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.153069e-01 | 0.501 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 3.153069e-01 | 0.501 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.153069e-01 | 0.501 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 2.215674e-01 | 0.654 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 2.215674e-01 | 0.654 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 2.215674e-01 | 0.654 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.215674e-01 | 0.654 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.215674e-01 | 0.654 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.215674e-01 | 0.654 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.215674e-01 | 0.654 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.637393e-01 | 0.786 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.464139e-01 | 0.834 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.464139e-01 | 0.834 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.464139e-01 | 0.834 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.948815e-01 | 0.710 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 1.948815e-01 | 0.710 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 2.679201e-01 | 0.572 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.965317e-01 | 0.402 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.965317e-01 | 0.402 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 3.965317e-01 | 0.402 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 3.965317e-01 | 0.402 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.965317e-01 | 0.402 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.965317e-01 | 0.402 | 0 | 0 |
| Defective ABCB6 causes MCOPCB7 | R-HSA-5683371 | 3.965317e-01 | 0.402 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.965317e-01 | 0.402 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 2.273158e-01 | 0.643 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.273158e-01 | 0.643 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.142329e-01 | 0.503 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.142329e-01 | 0.503 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.142329e-01 | 0.503 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 3.142329e-01 | 0.503 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.687033e-01 | 0.773 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 1.468749e-01 | 0.833 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 2.606647e-01 | 0.584 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.209407e-01 | 0.656 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.209407e-01 | 0.656 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 1.896789e-01 | 0.722 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.896789e-01 | 0.722 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 1.642425e-01 | 0.785 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 1.642425e-01 | 0.785 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 1.584673e-01 | 0.800 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.584673e-01 | 0.800 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.824335e-01 | 0.739 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 2.945783e-01 | 0.531 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.945783e-01 | 0.531 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.945783e-01 | 0.531 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.598635e-01 | 0.444 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.598635e-01 | 0.444 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 3.598635e-01 | 0.444 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.598635e-01 | 0.444 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 4.681250e-01 | 0.330 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 4.681250e-01 | 0.330 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 4.681250e-01 | 0.330 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.681250e-01 | 0.330 | 0 | 0 |
| Defective ABCD4 causes MAHCJ | R-HSA-5683329 | 4.681250e-01 | 0.330 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.681250e-01 | 0.330 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.681250e-01 | 0.330 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 4.681250e-01 | 0.330 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.681250e-01 | 0.330 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.745448e-01 | 0.758 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.751398e-01 | 0.560 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.912880e-01 | 0.718 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.210002e-01 | 0.656 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 3.287385e-01 | 0.483 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.287385e-01 | 0.483 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 3.287385e-01 | 0.483 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.573520e-01 | 0.589 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.573520e-01 | 0.589 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.573520e-01 | 0.589 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.412230e-01 | 0.618 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.412230e-01 | 0.618 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.412230e-01 | 0.618 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.043223e-01 | 0.393 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 4.043223e-01 | 0.393 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 4.043223e-01 | 0.393 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 4.043223e-01 | 0.393 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 2.131832e-01 | 0.671 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.619660e-01 | 0.582 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.619660e-01 | 0.582 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.619660e-01 | 0.582 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 3.628609e-01 | 0.440 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 3.628609e-01 | 0.440 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 3.311987e-01 | 0.480 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.052515e-01 | 0.515 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.930538e-01 | 0.714 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.930538e-01 | 0.714 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.180620e-01 | 0.661 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.180620e-01 | 0.661 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 2.319280e-01 | 0.635 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 2.471903e-01 | 0.607 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.471903e-01 | 0.607 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.046864e-01 | 0.516 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.296878e-01 | 0.482 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 3.594928e-01 | 0.444 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.966953e-01 | 0.402 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 4.472454e-01 | 0.349 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.472454e-01 | 0.349 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.472454e-01 | 0.349 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 5.312285e-01 | 0.275 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.312285e-01 | 0.275 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 5.312285e-01 | 0.275 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 5.312285e-01 | 0.275 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.312285e-01 | 0.275 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.312285e-01 | 0.275 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.312285e-01 | 0.275 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.312285e-01 | 0.275 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.310279e-01 | 0.636 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.877542e-01 | 0.411 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.300250e-01 | 0.367 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 4.300250e-01 | 0.367 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 4.300250e-01 | 0.367 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.931185e-01 | 0.533 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 2.894491e-01 | 0.538 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 4.158420e-01 | 0.381 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.883716e-01 | 0.311 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.883716e-01 | 0.311 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.308666e-01 | 0.480 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.461783e-01 | 0.609 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 4.626656e-01 | 0.335 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 4.626656e-01 | 0.335 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 4.626656e-01 | 0.335 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.289967e-01 | 0.483 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.657492e-01 | 0.437 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 3.068278e-01 | 0.513 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.149716e-01 | 0.382 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.149716e-01 | 0.382 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.149716e-01 | 0.382 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.833405e-01 | 0.416 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 3.745232e-01 | 0.427 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.586073e-01 | 0.445 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.444580e-01 | 0.463 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.709991e-01 | 0.327 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.275232e-01 | 0.278 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 5.275232e-01 | 0.278 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.589282e-01 | 0.338 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 4.187854e-01 | 0.378 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 4.978534e-01 | 0.303 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.978534e-01 | 0.303 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.538531e-01 | 0.343 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.252920e-01 | 0.280 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 5.002051e-01 | 0.301 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 5.002051e-01 | 0.301 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.473262e-01 | 0.349 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.864734e-01 | 0.313 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.241036e-01 | 0.281 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 5.241036e-01 | 0.281 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.645900e-01 | 0.248 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.645900e-01 | 0.248 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 5.645900e-01 | 0.248 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 5.645900e-01 | 0.248 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 5.035236e-01 | 0.298 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.035236e-01 | 0.298 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.035236e-01 | 0.298 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 5.048101e-01 | 0.297 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.048101e-01 | 0.297 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.750551e-01 | 0.323 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.550520e-01 | 0.256 | 0 | 0 |
| PKA activation | R-HSA-163615 | 5.550520e-01 | 0.256 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 5.229651e-01 | 0.282 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.438410e-01 | 0.265 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.421149e-01 | 0.266 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.408253e-01 | 0.267 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 5.524325e-01 | 0.258 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.584443e-01 | 0.253 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 5.684610e-01 | 0.245 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 5.745038e-01 | 0.241 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 5.836666e-01 | 0.234 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.578556e-01 | 0.589 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.750551e-01 | 0.323 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.053842e-01 | 0.687 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.405648e-01 | 0.619 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.604457e-01 | 0.795 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.002051e-01 | 0.301 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.641245e-01 | 0.578 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.830398e-01 | 0.417 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.368879e-01 | 0.270 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.564611e-01 | 0.255 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 4.810547e-01 | 0.318 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.059451e-01 | 0.296 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 2.831476e-01 | 0.548 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 3.553108e-01 | 0.449 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 3.553108e-01 | 0.449 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 4.906712e-01 | 0.309 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 3.287385e-01 | 0.483 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.030259e-01 | 0.519 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.210002e-01 | 0.656 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.757685e-01 | 0.240 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.467368e-01 | 0.608 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.794072e-01 | 0.237 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.700963e-01 | 0.769 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.013777e-01 | 0.696 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.308666e-01 | 0.480 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.830398e-01 | 0.417 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.430508e-01 | 0.614 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.086462e-01 | 0.681 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.467368e-01 | 0.608 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.745448e-01 | 0.758 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 4.158420e-01 | 0.381 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.954824e-01 | 0.529 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 3.553108e-01 | 0.449 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.883716e-01 | 0.311 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.180483e-01 | 0.661 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.789835e-01 | 0.421 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.209407e-01 | 0.656 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.013777e-01 | 0.696 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.815500e-01 | 0.741 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.883716e-01 | 0.311 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.036789e-01 | 0.394 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 5.641587e-01 | 0.249 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 5.550520e-01 | 0.256 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.735670e-01 | 0.428 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.273158e-01 | 0.643 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 1.468749e-01 | 0.833 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.598635e-01 | 0.444 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.627636e-01 | 0.440 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.626656e-01 | 0.335 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 3.735670e-01 | 0.428 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 4.370284e-01 | 0.359 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 5.002051e-01 | 0.301 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 5.234560e-01 | 0.281 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.231104e-01 | 0.281 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.311987e-01 | 0.480 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.745448e-01 | 0.758 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.857024e-01 | 0.544 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.521562e-01 | 0.818 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 3.287385e-01 | 0.483 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.896056e-01 | 0.722 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.851099e-01 | 0.733 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.914755e-01 | 0.407 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.573520e-01 | 0.589 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.147080e-01 | 0.288 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.805048e-01 | 0.744 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.760023e-01 | 0.754 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.945783e-01 | 0.531 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.751398e-01 | 0.560 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.912880e-01 | 0.718 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.043223e-01 | 0.393 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.311987e-01 | 0.480 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.467368e-01 | 0.608 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 5.312285e-01 | 0.275 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.630607e-01 | 0.788 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.857024e-01 | 0.544 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.229377e-01 | 0.282 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.378074e-01 | 0.471 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 2.210002e-01 | 0.656 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.627636e-01 | 0.440 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.851041e-01 | 0.545 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 3.371729e-01 | 0.472 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.670379e-01 | 0.777 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.231263e-01 | 0.491 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.013777e-01 | 0.696 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.297414e-01 | 0.639 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.594928e-01 | 0.444 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.524937e-01 | 0.344 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 4.806117e-01 | 0.318 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.009099e-01 | 0.697 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.520388e-01 | 0.818 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.569432e-01 | 0.447 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.713456e-01 | 0.327 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 2.831476e-01 | 0.548 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.046864e-01 | 0.516 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.370284e-01 | 0.359 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.547549e-01 | 0.810 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.605313e-01 | 0.337 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.313638e-01 | 0.636 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.215674e-01 | 0.654 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 3.598635e-01 | 0.444 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.751398e-01 | 0.560 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.265649e-01 | 0.645 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.604457e-01 | 0.795 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.620249e-01 | 0.790 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 3.966953e-01 | 0.402 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 4.472454e-01 | 0.349 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.310279e-01 | 0.636 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.877542e-01 | 0.411 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.894491e-01 | 0.538 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 4.158420e-01 | 0.381 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 2.278608e-01 | 0.642 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.370284e-01 | 0.359 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.275232e-01 | 0.278 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.978534e-01 | 0.303 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.252920e-01 | 0.280 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.645900e-01 | 0.248 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.901385e-01 | 0.310 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 5.438410e-01 | 0.265 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.506599e-01 | 0.455 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 3.928890e-01 | 0.406 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.311987e-01 | 0.480 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.366648e-01 | 0.473 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.366648e-01 | 0.473 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 4.828876e-01 | 0.316 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.831476e-01 | 0.548 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.225284e-01 | 0.491 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.380091e-01 | 0.471 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.370284e-01 | 0.359 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.300250e-01 | 0.367 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 5.496747e-01 | 0.260 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 5.496747e-01 | 0.260 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.457526e-01 | 0.610 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.457526e-01 | 0.610 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.457526e-01 | 0.610 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.457526e-01 | 0.610 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.816144e-01 | 0.235 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.115228e-01 | 0.675 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.265014e-01 | 0.486 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.300250e-01 | 0.367 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.408517e-01 | 0.356 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.446853e-01 | 0.352 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.181759e-01 | 0.497 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.875273e-01 | 0.541 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.186381e-01 | 0.378 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.948815e-01 | 0.710 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.679201e-01 | 0.572 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 2.209407e-01 | 0.656 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.746289e-01 | 0.561 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.709991e-01 | 0.327 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 5.609391e-01 | 0.251 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.763235e-01 | 0.754 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.552796e-01 | 0.342 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.110543e-01 | 0.676 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 3.425738e-01 | 0.465 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.285030e-01 | 0.641 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.319280e-01 | 0.635 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.706447e-01 | 0.431 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.493398e-01 | 0.603 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.745821e-01 | 0.561 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.142329e-01 | 0.503 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.265649e-01 | 0.645 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.582301e-01 | 0.801 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.810744e-01 | 0.742 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.501985e-01 | 0.602 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.639168e-01 | 0.334 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 5.018859e-01 | 0.299 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.831476e-01 | 0.548 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.600549e-01 | 0.585 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.472454e-01 | 0.349 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.052515e-01 | 0.515 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.681857e-01 | 0.774 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.305512e-01 | 0.366 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.305512e-01 | 0.366 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.143924e-01 | 0.503 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.641245e-01 | 0.578 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.950028e-01 | 0.710 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.378074e-01 | 0.471 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.711573e-01 | 0.767 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.265649e-01 | 0.645 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.453112e-01 | 0.351 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 3.366648e-01 | 0.473 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.795916e-01 | 0.746 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.578553e-01 | 0.802 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.231556e-01 | 0.651 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.153069e-01 | 0.501 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 2.215674e-01 | 0.654 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.948815e-01 | 0.710 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.965317e-01 | 0.402 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.965317e-01 | 0.402 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.965317e-01 | 0.402 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.965317e-01 | 0.402 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 2.606647e-01 | 0.584 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.209407e-01 | 0.656 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.477166e-01 | 0.606 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.521562e-01 | 0.818 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.573520e-01 | 0.589 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.628609e-01 | 0.440 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.896056e-01 | 0.722 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.694617e-01 | 0.771 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 2.831476e-01 | 0.548 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.472454e-01 | 0.349 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.312285e-01 | 0.275 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.482453e-01 | 0.458 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 4.626656e-01 | 0.335 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 5.241036e-01 | 0.281 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.152447e-01 | 0.288 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.836666e-01 | 0.234 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.637565e-01 | 0.786 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.685708e-01 | 0.571 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.390800e-01 | 0.268 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.910892e-01 | 0.536 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.998912e-01 | 0.523 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.911430e-01 | 0.408 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 5.373777e-01 | 0.270 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.140023e-01 | 0.670 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.127006e-01 | 0.672 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 5.496747e-01 | 0.260 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.587132e-01 | 0.799 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.425464e-01 | 0.615 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.313638e-01 | 0.636 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.641245e-01 | 0.578 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 4.300250e-01 | 0.367 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.305512e-01 | 0.366 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 4.300250e-01 | 0.367 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 5.836666e-01 | 0.234 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.428045e-01 | 0.354 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.669987e-01 | 0.573 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 3.030259e-01 | 0.519 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.168751e-01 | 0.664 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.252920e-01 | 0.280 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.815500e-01 | 0.741 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.620249e-01 | 0.790 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.229651e-01 | 0.282 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.831087e-01 | 0.548 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.026866e-01 | 0.519 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.376589e-01 | 0.269 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.948815e-01 | 0.710 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.966953e-01 | 0.402 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 4.158420e-01 | 0.381 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 4.944632e-01 | 0.306 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.645952e-01 | 0.333 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.175554e-01 | 0.662 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.641329e-01 | 0.785 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.807021e-01 | 0.318 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.026866e-01 | 0.519 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.781487e-01 | 0.556 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.610365e-01 | 0.251 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.838274e-01 | 0.315 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 4.499681e-01 | 0.347 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.159256e-01 | 0.666 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.948815e-01 | 0.710 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.948815e-01 | 0.710 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.815500e-01 | 0.741 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.511371e-01 | 0.821 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.131832e-01 | 0.671 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.312285e-01 | 0.275 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 4.626656e-01 | 0.335 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.462248e-01 | 0.263 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.471903e-01 | 0.607 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 3.415274e-01 | 0.467 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.635876e-01 | 0.786 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.657492e-01 | 0.437 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 5.745038e-01 | 0.241 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.488796e-01 | 0.604 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.252920e-01 | 0.280 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.665004e-01 | 0.574 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.273158e-01 | 0.643 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.438410e-01 | 0.265 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.438410e-01 | 0.265 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 3.287385e-01 | 0.483 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.153069e-01 | 0.501 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 3.153069e-01 | 0.501 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 3.142329e-01 | 0.503 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 2.606647e-01 | 0.584 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.681250e-01 | 0.330 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.043223e-01 | 0.393 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.265649e-01 | 0.645 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.265649e-01 | 0.645 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.457526e-01 | 0.610 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 5.645900e-01 | 0.248 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.645900e-01 | 0.248 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 5.684610e-01 | 0.245 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.943815e-01 | 0.404 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.412230e-01 | 0.618 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 2.412230e-01 | 0.618 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.309354e-01 | 0.637 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.700963e-01 | 0.769 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.209407e-01 | 0.656 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 5.234560e-01 | 0.281 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.289967e-01 | 0.483 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.811015e-01 | 0.551 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.831087e-01 | 0.548 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.472454e-01 | 0.349 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.186381e-01 | 0.378 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.550520e-01 | 0.256 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.438410e-01 | 0.265 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.013777e-01 | 0.696 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.052515e-01 | 0.515 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.471903e-01 | 0.607 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 2.811015e-01 | 0.551 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.818583e-01 | 0.550 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 3.965317e-01 | 0.402 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.598635e-01 | 0.444 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.587132e-01 | 0.799 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 5.550520e-01 | 0.256 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 5.241494e-01 | 0.281 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.035261e-01 | 0.691 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.726748e-01 | 0.564 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.864734e-01 | 0.313 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.241036e-01 | 0.281 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.241036e-01 | 0.281 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.149716e-01 | 0.382 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.836666e-01 | 0.234 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.362730e-01 | 0.360 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 5.370026e-01 | 0.270 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 2.606647e-01 | 0.584 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.965317e-01 | 0.402 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 3.598635e-01 | 0.444 | 0 | 0 |
| NGF processing | R-HSA-167060 | 4.681250e-01 | 0.330 | 0 | 0 |
| Expression and Processing of Neurotrophins | R-HSA-9036866 | 4.681250e-01 | 0.330 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.043223e-01 | 0.393 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.628609e-01 | 0.440 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.472454e-01 | 0.349 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.472454e-01 | 0.349 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.472454e-01 | 0.349 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.020244e-01 | 0.299 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.311987e-01 | 0.480 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 4.626656e-01 | 0.335 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.564611e-01 | 0.255 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.883716e-01 | 0.311 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 4.626656e-01 | 0.335 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 5.252920e-01 | 0.280 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.411217e-01 | 0.355 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 5.584443e-01 | 0.253 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.883716e-01 | 0.311 | 0 | 0 |
| Synthesis and processing of ENV and VPU | R-HSA-171286 | 3.965317e-01 | 0.402 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.046864e-01 | 0.516 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 5.840328e-01 | 0.234 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 5.840328e-01 | 0.234 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 5.840328e-01 | 0.234 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 5.840328e-01 | 0.234 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 5.840328e-01 | 0.234 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 5.840328e-01 | 0.234 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.868483e-01 | 0.231 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.868483e-01 | 0.231 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 5.868483e-01 | 0.231 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 5.868483e-01 | 0.231 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.868483e-01 | 0.231 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.868483e-01 | 0.231 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.868483e-01 | 0.231 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.868483e-01 | 0.231 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.868483e-01 | 0.231 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 5.868483e-01 | 0.231 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 5.868483e-01 | 0.231 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.869492e-01 | 0.231 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 5.870972e-01 | 0.231 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.899211e-01 | 0.229 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.901214e-01 | 0.229 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 5.901214e-01 | 0.229 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 5.901214e-01 | 0.229 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.921088e-01 | 0.228 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.974739e-01 | 0.224 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 5.974916e-01 | 0.224 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.974916e-01 | 0.224 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 5.974916e-01 | 0.224 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.985395e-01 | 0.223 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.985395e-01 | 0.223 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.985395e-01 | 0.223 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 5.985395e-01 | 0.223 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.985395e-01 | 0.223 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 5.995154e-01 | 0.222 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.995154e-01 | 0.222 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.995154e-01 | 0.222 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 5.995154e-01 | 0.222 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 5.995154e-01 | 0.222 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 5.995154e-01 | 0.222 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 5.995154e-01 | 0.222 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 5.995154e-01 | 0.222 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.995154e-01 | 0.222 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.995154e-01 | 0.222 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 5.995154e-01 | 0.222 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.110801e-01 | 0.214 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.152199e-01 | 0.211 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.156184e-01 | 0.211 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.182588e-01 | 0.209 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.182588e-01 | 0.209 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.182588e-01 | 0.209 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.182588e-01 | 0.209 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.216971e-01 | 0.206 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.223276e-01 | 0.206 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 6.223276e-01 | 0.206 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 6.254743e-01 | 0.204 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.256210e-01 | 0.204 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 6.257457e-01 | 0.204 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 6.315744e-01 | 0.200 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 6.316668e-01 | 0.200 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 6.322857e-01 | 0.199 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 6.322857e-01 | 0.199 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 6.322857e-01 | 0.199 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 6.322857e-01 | 0.199 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.324157e-01 | 0.199 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.337171e-01 | 0.198 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.349021e-01 | 0.197 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.358717e-01 | 0.197 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.358717e-01 | 0.197 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 6.358717e-01 | 0.197 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.358717e-01 | 0.197 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 6.358717e-01 | 0.197 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 6.358717e-01 | 0.197 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.358717e-01 | 0.197 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.358717e-01 | 0.197 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.358717e-01 | 0.197 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.358717e-01 | 0.197 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 6.358717e-01 | 0.197 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.358717e-01 | 0.197 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 6.358717e-01 | 0.197 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.358717e-01 | 0.197 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.358717e-01 | 0.197 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.372552e-01 | 0.196 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 6.372552e-01 | 0.196 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 6.372552e-01 | 0.196 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.372552e-01 | 0.196 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.372552e-01 | 0.196 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.372552e-01 | 0.196 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.393115e-01 | 0.194 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.393115e-01 | 0.194 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 6.406977e-01 | 0.193 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 6.408893e-01 | 0.193 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 6.416757e-01 | 0.193 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 6.440767e-01 | 0.191 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.440767e-01 | 0.191 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 6.443779e-01 | 0.191 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 6.443779e-01 | 0.191 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 6.443779e-01 | 0.191 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.448198e-01 | 0.191 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.492158e-01 | 0.188 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.492158e-01 | 0.188 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.499763e-01 | 0.187 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.502682e-01 | 0.187 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 6.513125e-01 | 0.186 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.517286e-01 | 0.186 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.527320e-01 | 0.185 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.557111e-01 | 0.183 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.558985e-01 | 0.183 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.572150e-01 | 0.182 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 6.572150e-01 | 0.182 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.572150e-01 | 0.182 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 6.585227e-01 | 0.181 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 6.585227e-01 | 0.181 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 6.585227e-01 | 0.181 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 6.585227e-01 | 0.181 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 6.605784e-01 | 0.180 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 6.621709e-01 | 0.179 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.621709e-01 | 0.179 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 6.629207e-01 | 0.179 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 6.629207e-01 | 0.179 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 6.629207e-01 | 0.179 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 6.629207e-01 | 0.179 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.634816e-01 | 0.178 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 6.639747e-01 | 0.178 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 6.655253e-01 | 0.177 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.655253e-01 | 0.177 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.719196e-01 | 0.173 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 6.730328e-01 | 0.172 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 6.737270e-01 | 0.172 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.750147e-01 | 0.171 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.750147e-01 | 0.171 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.757873e-01 | 0.170 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 6.760460e-01 | 0.170 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.789020e-01 | 0.168 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.790807e-01 | 0.168 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.790807e-01 | 0.168 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.790807e-01 | 0.168 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 6.790807e-01 | 0.168 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 6.790807e-01 | 0.168 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.790807e-01 | 0.168 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 6.790807e-01 | 0.168 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 6.790807e-01 | 0.168 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 6.790807e-01 | 0.168 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 6.790807e-01 | 0.168 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 6.790807e-01 | 0.168 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 6.790807e-01 | 0.168 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.790807e-01 | 0.168 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.790807e-01 | 0.168 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.790807e-01 | 0.168 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 6.790807e-01 | 0.168 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.790807e-01 | 0.168 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.803223e-01 | 0.167 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.814156e-01 | 0.167 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.835920e-01 | 0.165 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.852215e-01 | 0.164 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.858200e-01 | 0.164 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 6.858200e-01 | 0.164 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 6.860724e-01 | 0.164 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.870732e-01 | 0.163 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 6.887178e-01 | 0.162 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.914366e-01 | 0.160 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.914656e-01 | 0.160 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.914656e-01 | 0.160 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.914656e-01 | 0.160 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.914656e-01 | 0.160 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 6.914656e-01 | 0.160 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 6.914656e-01 | 0.160 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 6.914656e-01 | 0.160 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.914656e-01 | 0.160 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 6.914656e-01 | 0.160 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 6.914656e-01 | 0.160 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.967927e-01 | 0.157 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 6.967927e-01 | 0.157 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.031276e-01 | 0.153 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.031276e-01 | 0.153 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.057117e-01 | 0.151 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 7.057117e-01 | 0.151 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.060687e-01 | 0.151 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.063630e-01 | 0.151 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.063630e-01 | 0.151 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.063630e-01 | 0.151 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.082074e-01 | 0.150 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.082074e-01 | 0.150 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.082074e-01 | 0.150 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.082074e-01 | 0.150 | 0 | 0 |
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | R-HSA-159782 | 7.171645e-01 | 0.144 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 7.171645e-01 | 0.144 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 7.171645e-01 | 0.144 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 7.171645e-01 | 0.144 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 7.171645e-01 | 0.144 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.171645e-01 | 0.144 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 7.171645e-01 | 0.144 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 7.171645e-01 | 0.144 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.171645e-01 | 0.144 | 0 | 0 |
| Mitochondrial ABC transporters | R-HSA-1369007 | 7.171645e-01 | 0.144 | 0 | 0 |
| Opsins | R-HSA-419771 | 7.171645e-01 | 0.144 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.171645e-01 | 0.144 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 7.171645e-01 | 0.144 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 7.171645e-01 | 0.144 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.171645e-01 | 0.144 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.171645e-01 | 0.144 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 7.171645e-01 | 0.144 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 7.171645e-01 | 0.144 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 7.179850e-01 | 0.144 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 7.179850e-01 | 0.144 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 7.179850e-01 | 0.144 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 7.179850e-01 | 0.144 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 7.179850e-01 | 0.144 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.190850e-01 | 0.143 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.190850e-01 | 0.143 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 7.191074e-01 | 0.143 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 7.197345e-01 | 0.143 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.230726e-01 | 0.141 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 7.232962e-01 | 0.141 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 7.260641e-01 | 0.139 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.293480e-01 | 0.137 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.293480e-01 | 0.137 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.293480e-01 | 0.137 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 7.329899e-01 | 0.135 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.335957e-01 | 0.135 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.335957e-01 | 0.135 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.379025e-01 | 0.132 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 7.384556e-01 | 0.132 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.393085e-01 | 0.131 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.395172e-01 | 0.131 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.395172e-01 | 0.131 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.395172e-01 | 0.131 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 7.395172e-01 | 0.131 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.399503e-01 | 0.131 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 7.416853e-01 | 0.130 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 7.419930e-01 | 0.130 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.422721e-01 | 0.129 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 7.422721e-01 | 0.129 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 7.425576e-01 | 0.129 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 7.425576e-01 | 0.129 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 7.425576e-01 | 0.129 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 7.425576e-01 | 0.129 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 7.425576e-01 | 0.129 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.425576e-01 | 0.129 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.439626e-01 | 0.128 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.455755e-01 | 0.128 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.492653e-01 | 0.125 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.492653e-01 | 0.125 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.492653e-01 | 0.125 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 7.494647e-01 | 0.125 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.507308e-01 | 0.125 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.507308e-01 | 0.125 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.507308e-01 | 0.125 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.507308e-01 | 0.125 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.507308e-01 | 0.125 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.507308e-01 | 0.125 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.507308e-01 | 0.125 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.507308e-01 | 0.125 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.507308e-01 | 0.125 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 7.507308e-01 | 0.125 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.507308e-01 | 0.125 | 0 | 0 |
| RSK activation | R-HSA-444257 | 7.507308e-01 | 0.125 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.507308e-01 | 0.125 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.507308e-01 | 0.125 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.507308e-01 | 0.125 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 7.507308e-01 | 0.125 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 7.510930e-01 | 0.124 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 7.534086e-01 | 0.123 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.556079e-01 | 0.122 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.592096e-01 | 0.120 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.592096e-01 | 0.120 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.592096e-01 | 0.120 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.652719e-01 | 0.116 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.652719e-01 | 0.116 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 7.652719e-01 | 0.116 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.652719e-01 | 0.116 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.662193e-01 | 0.116 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 7.663766e-01 | 0.116 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.671753e-01 | 0.115 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 7.672877e-01 | 0.115 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 7.679895e-01 | 0.115 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.679895e-01 | 0.115 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.679895e-01 | 0.115 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 7.684287e-01 | 0.114 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 7.684287e-01 | 0.114 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 7.684287e-01 | 0.114 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 7.687229e-01 | 0.114 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.716258e-01 | 0.113 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.720041e-01 | 0.112 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 7.752706e-01 | 0.111 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 7.752706e-01 | 0.111 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.752706e-01 | 0.111 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 7.780676e-01 | 0.109 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 7.780676e-01 | 0.109 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 7.783679e-01 | 0.109 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 7.786059e-01 | 0.109 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.786059e-01 | 0.109 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.796971e-01 | 0.108 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.799551e-01 | 0.108 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 7.803153e-01 | 0.108 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 7.803153e-01 | 0.108 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 7.803153e-01 | 0.108 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.803153e-01 | 0.108 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.803153e-01 | 0.108 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.803153e-01 | 0.108 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 7.803153e-01 | 0.108 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.803153e-01 | 0.108 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.803153e-01 | 0.108 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.803153e-01 | 0.108 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.803153e-01 | 0.108 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.803153e-01 | 0.108 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.803153e-01 | 0.108 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 7.810459e-01 | 0.107 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 7.839569e-01 | 0.106 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 7.855566e-01 | 0.105 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.856552e-01 | 0.105 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 7.862228e-01 | 0.104 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.862228e-01 | 0.104 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.862228e-01 | 0.104 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 7.862228e-01 | 0.104 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 7.862228e-01 | 0.104 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.862228e-01 | 0.104 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.904738e-01 | 0.102 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 7.904738e-01 | 0.102 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.904738e-01 | 0.102 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.930412e-01 | 0.101 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.930412e-01 | 0.101 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.020067e-01 | 0.096 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.020067e-01 | 0.096 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.020067e-01 | 0.096 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 8.020067e-01 | 0.096 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.020067e-01 | 0.096 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.048410e-01 | 0.094 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 8.049992e-01 | 0.094 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.050284e-01 | 0.094 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.055087e-01 | 0.094 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.055087e-01 | 0.094 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.055087e-01 | 0.094 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.055087e-01 | 0.094 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 8.055087e-01 | 0.094 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.055087e-01 | 0.094 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.063417e-01 | 0.093 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 8.063901e-01 | 0.093 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 8.063901e-01 | 0.093 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.063901e-01 | 0.093 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 8.063901e-01 | 0.093 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 8.063901e-01 | 0.093 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.063901e-01 | 0.093 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 8.063901e-01 | 0.093 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 8.063901e-01 | 0.093 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 8.063901e-01 | 0.093 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 8.063901e-01 | 0.093 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 8.087982e-01 | 0.092 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.122065e-01 | 0.090 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 8.173832e-01 | 0.088 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 8.173832e-01 | 0.088 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.173832e-01 | 0.088 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.173832e-01 | 0.088 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.179597e-01 | 0.087 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.206282e-01 | 0.086 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.222839e-01 | 0.085 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.232298e-01 | 0.084 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.232298e-01 | 0.084 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.232298e-01 | 0.084 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 8.232298e-01 | 0.084 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.232298e-01 | 0.084 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.232298e-01 | 0.084 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 8.232298e-01 | 0.084 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 8.232298e-01 | 0.084 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 8.232298e-01 | 0.084 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 8.293713e-01 | 0.081 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 8.293713e-01 | 0.081 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 8.293713e-01 | 0.081 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 8.293713e-01 | 0.081 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.293713e-01 | 0.081 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 8.293713e-01 | 0.081 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 8.293713e-01 | 0.081 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.293713e-01 | 0.081 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.293713e-01 | 0.081 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 8.293713e-01 | 0.081 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 8.293713e-01 | 0.081 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 8.293713e-01 | 0.081 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 8.293713e-01 | 0.081 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.293713e-01 | 0.081 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.293713e-01 | 0.081 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.293713e-01 | 0.081 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.293713e-01 | 0.081 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.311669e-01 | 0.080 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.311669e-01 | 0.080 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.311669e-01 | 0.080 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.337709e-01 | 0.079 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.337709e-01 | 0.079 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.343309e-01 | 0.079 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.394857e-01 | 0.076 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.394857e-01 | 0.076 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.409184e-01 | 0.075 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 8.412002e-01 | 0.075 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.431799e-01 | 0.074 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.431799e-01 | 0.074 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.451002e-01 | 0.073 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.451002e-01 | 0.073 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 8.478230e-01 | 0.072 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.496259e-01 | 0.071 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 8.496259e-01 | 0.071 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 8.496259e-01 | 0.071 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 8.496259e-01 | 0.071 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 8.496259e-01 | 0.071 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 8.496259e-01 | 0.071 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 8.496259e-01 | 0.071 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.496259e-01 | 0.071 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 8.496259e-01 | 0.071 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 8.496259e-01 | 0.071 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.496259e-01 | 0.071 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 8.496259e-01 | 0.071 | 0 | 0 |
| Uptake of dietary cobalamins into enterocytes | R-HSA-9758881 | 8.496259e-01 | 0.071 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 8.496259e-01 | 0.071 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.543745e-01 | 0.068 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.543745e-01 | 0.068 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.544647e-01 | 0.068 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.544647e-01 | 0.068 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.544647e-01 | 0.068 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.551635e-01 | 0.068 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 8.588382e-01 | 0.066 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.588382e-01 | 0.066 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.610948e-01 | 0.065 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.610948e-01 | 0.065 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.650514e-01 | 0.063 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.655887e-01 | 0.063 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 8.674772e-01 | 0.062 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.674772e-01 | 0.062 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.674772e-01 | 0.062 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.674772e-01 | 0.062 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.674772e-01 | 0.062 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 8.674772e-01 | 0.062 | 0 | 0 |
| Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | R-HSA-159854 | 8.674772e-01 | 0.062 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.674772e-01 | 0.062 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.674772e-01 | 0.062 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.674772e-01 | 0.062 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.674772e-01 | 0.062 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.679916e-01 | 0.061 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 8.679916e-01 | 0.061 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 8.679916e-01 | 0.061 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.688155e-01 | 0.061 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.690887e-01 | 0.061 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 8.690887e-01 | 0.061 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.690887e-01 | 0.061 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 8.700023e-01 | 0.060 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.729989e-01 | 0.059 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.757772e-01 | 0.058 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.766831e-01 | 0.057 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.792420e-01 | 0.056 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.798055e-01 | 0.056 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.802927e-01 | 0.055 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.804291e-01 | 0.055 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 8.804291e-01 | 0.055 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.804291e-01 | 0.055 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.825727e-01 | 0.054 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 8.826292e-01 | 0.054 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 8.826292e-01 | 0.054 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.832102e-01 | 0.054 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.832102e-01 | 0.054 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.832102e-01 | 0.054 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.832102e-01 | 0.054 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.832102e-01 | 0.054 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.832102e-01 | 0.054 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.832102e-01 | 0.054 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.859892e-01 | 0.053 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 8.877026e-01 | 0.052 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.897344e-01 | 0.051 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.897344e-01 | 0.051 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.897344e-01 | 0.051 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.897344e-01 | 0.051 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.897344e-01 | 0.051 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.905154e-01 | 0.050 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.920643e-01 | 0.050 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.928174e-01 | 0.049 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.929275e-01 | 0.049 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.929275e-01 | 0.049 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.952470e-01 | 0.048 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.970763e-01 | 0.047 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.970763e-01 | 0.047 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.970763e-01 | 0.047 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.970763e-01 | 0.047 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.970763e-01 | 0.047 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 8.970763e-01 | 0.047 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.970763e-01 | 0.047 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.970763e-01 | 0.047 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.970763e-01 | 0.047 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.970763e-01 | 0.047 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.970763e-01 | 0.047 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.974906e-01 | 0.047 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.989133e-01 | 0.046 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 8.989221e-01 | 0.046 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.021132e-01 | 0.045 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.021132e-01 | 0.045 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.021132e-01 | 0.045 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 9.053025e-01 | 0.043 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.074138e-01 | 0.042 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.074138e-01 | 0.042 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.085802e-01 | 0.042 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 9.092967e-01 | 0.041 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.092967e-01 | 0.041 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 9.092967e-01 | 0.041 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 9.092967e-01 | 0.041 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 9.092967e-01 | 0.041 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 9.092967e-01 | 0.041 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 9.092967e-01 | 0.041 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 9.092967e-01 | 0.041 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 9.092967e-01 | 0.041 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.104613e-01 | 0.041 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.108986e-01 | 0.041 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.108986e-01 | 0.041 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.115230e-01 | 0.040 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.115230e-01 | 0.040 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.144897e-01 | 0.039 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.152537e-01 | 0.038 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.185531e-01 | 0.037 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.185531e-01 | 0.037 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.199421e-01 | 0.036 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.200669e-01 | 0.036 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 9.200669e-01 | 0.036 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 9.200669e-01 | 0.036 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.200669e-01 | 0.036 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 9.200669e-01 | 0.036 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 9.200669e-01 | 0.036 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.200790e-01 | 0.036 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.200790e-01 | 0.036 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 9.200790e-01 | 0.036 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.200790e-01 | 0.036 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.200790e-01 | 0.036 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.213356e-01 | 0.036 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.221653e-01 | 0.035 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.221653e-01 | 0.035 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.234111e-01 | 0.035 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.242095e-01 | 0.034 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.261538e-01 | 0.033 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.278383e-01 | 0.033 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.278513e-01 | 0.033 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.278513e-01 | 0.033 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.282199e-01 | 0.032 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.291452e-01 | 0.032 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 9.295587e-01 | 0.032 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.295587e-01 | 0.032 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.295587e-01 | 0.032 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.295587e-01 | 0.032 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.295587e-01 | 0.032 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 9.295587e-01 | 0.032 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 9.295587e-01 | 0.032 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.295587e-01 | 0.032 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.323815e-01 | 0.030 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.349053e-01 | 0.029 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.349053e-01 | 0.029 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.349053e-01 | 0.029 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.352530e-01 | 0.029 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.359584e-01 | 0.029 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.379239e-01 | 0.028 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.379239e-01 | 0.028 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.379239e-01 | 0.028 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.379239e-01 | 0.028 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.379239e-01 | 0.028 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.379239e-01 | 0.028 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.391569e-01 | 0.027 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.391569e-01 | 0.027 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.396877e-01 | 0.027 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.413020e-01 | 0.026 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.416892e-01 | 0.026 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.430118e-01 | 0.025 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.440227e-01 | 0.025 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.440793e-01 | 0.025 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.451518e-01 | 0.024 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.451518e-01 | 0.024 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.452961e-01 | 0.024 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.452961e-01 | 0.024 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 9.452961e-01 | 0.024 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.452961e-01 | 0.024 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 9.452961e-01 | 0.024 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.452961e-01 | 0.024 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.455594e-01 | 0.024 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.460939e-01 | 0.024 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.470979e-01 | 0.024 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.485303e-01 | 0.023 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 9.517932e-01 | 0.021 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.517932e-01 | 0.021 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.517932e-01 | 0.021 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.517932e-01 | 0.021 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.517932e-01 | 0.021 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.517932e-01 | 0.021 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.517932e-01 | 0.021 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.517932e-01 | 0.021 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.517932e-01 | 0.021 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.522610e-01 | 0.021 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.525390e-01 | 0.021 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.532784e-01 | 0.021 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.549868e-01 | 0.020 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.551231e-01 | 0.020 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.558899e-01 | 0.020 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.558930e-01 | 0.020 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.570934e-01 | 0.019 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.575189e-01 | 0.019 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.575189e-01 | 0.019 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.575189e-01 | 0.019 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.575189e-01 | 0.019 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.575189e-01 | 0.019 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.575189e-01 | 0.019 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.591888e-01 | 0.018 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.592651e-01 | 0.018 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.607534e-01 | 0.017 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.613860e-01 | 0.017 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.613860e-01 | 0.017 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.613860e-01 | 0.017 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.625649e-01 | 0.017 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.625649e-01 | 0.017 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.625649e-01 | 0.017 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.625649e-01 | 0.017 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.628658e-01 | 0.016 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.628658e-01 | 0.016 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.632383e-01 | 0.016 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.652646e-01 | 0.015 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.652646e-01 | 0.015 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.652646e-01 | 0.015 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.652646e-01 | 0.015 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.658518e-01 | 0.015 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.658518e-01 | 0.015 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.662149e-01 | 0.015 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.662149e-01 | 0.015 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 9.670118e-01 | 0.015 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.670118e-01 | 0.015 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.670118e-01 | 0.015 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.670118e-01 | 0.015 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.670118e-01 | 0.015 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.670118e-01 | 0.015 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.680197e-01 | 0.014 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.687668e-01 | 0.014 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.692627e-01 | 0.014 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.701720e-01 | 0.013 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.705278e-01 | 0.013 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.709306e-01 | 0.013 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.709306e-01 | 0.013 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.709306e-01 | 0.013 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.709306e-01 | 0.013 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.709306e-01 | 0.013 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.711332e-01 | 0.013 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.718451e-01 | 0.012 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.719275e-01 | 0.012 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.723950e-01 | 0.012 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 9.728525e-01 | 0.012 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.728525e-01 | 0.012 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.731008e-01 | 0.012 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.741111e-01 | 0.011 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.743842e-01 | 0.011 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.743842e-01 | 0.011 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.746319e-01 | 0.011 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.746319e-01 | 0.011 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.747782e-01 | 0.011 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.747782e-01 | 0.011 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.749451e-01 | 0.011 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.764119e-01 | 0.010 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.773480e-01 | 0.010 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.773480e-01 | 0.010 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.773480e-01 | 0.010 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.774276e-01 | 0.010 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.774276e-01 | 0.010 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.774276e-01 | 0.010 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.774276e-01 | 0.010 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.774276e-01 | 0.010 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.774276e-01 | 0.010 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.774276e-01 | 0.010 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.796635e-01 | 0.009 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.797980e-01 | 0.009 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.801095e-01 | 0.009 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.801095e-01 | 0.009 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.801095e-01 | 0.009 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.801095e-01 | 0.009 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.801095e-01 | 0.009 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.815517e-01 | 0.008 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.817486e-01 | 0.008 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.817486e-01 | 0.008 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.817486e-01 | 0.008 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.824730e-01 | 0.008 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.824730e-01 | 0.008 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.824730e-01 | 0.008 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.824730e-01 | 0.008 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.824730e-01 | 0.008 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.824730e-01 | 0.008 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.824730e-01 | 0.008 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.825450e-01 | 0.008 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.828203e-01 | 0.008 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.832322e-01 | 0.007 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.833460e-01 | 0.007 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.836255e-01 | 0.007 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.836255e-01 | 0.007 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.838089e-01 | 0.007 | 0 | 0 |
| Translation | R-HSA-72766 | 9.838239e-01 | 0.007 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.840748e-01 | 0.007 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.845557e-01 | 0.007 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.845557e-01 | 0.007 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.845557e-01 | 0.007 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.853143e-01 | 0.006 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.854160e-01 | 0.006 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.858699e-01 | 0.006 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.863911e-01 | 0.006 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.863911e-01 | 0.006 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.863911e-01 | 0.006 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.868330e-01 | 0.006 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.868330e-01 | 0.006 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.868330e-01 | 0.006 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.868330e-01 | 0.006 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.872013e-01 | 0.006 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.880084e-01 | 0.005 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.881983e-01 | 0.005 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.881983e-01 | 0.005 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.890323e-01 | 0.005 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.894251e-01 | 0.005 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.894251e-01 | 0.005 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.894336e-01 | 0.005 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.894336e-01 | 0.005 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.894336e-01 | 0.005 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.895115e-01 | 0.005 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.898489e-01 | 0.004 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.898805e-01 | 0.004 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.906895e-01 | 0.004 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.914170e-01 | 0.004 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.916701e-01 | 0.004 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.916701e-01 | 0.004 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.916701e-01 | 0.004 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.917962e-01 | 0.004 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.920233e-01 | 0.003 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.922398e-01 | 0.003 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.922398e-01 | 0.003 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.924049e-01 | 0.003 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.924608e-01 | 0.003 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.936307e-01 | 0.003 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.936307e-01 | 0.003 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.936307e-01 | 0.003 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.938443e-01 | 0.003 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.940762e-01 | 0.003 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.943880e-01 | 0.002 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.943880e-01 | 0.002 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.943880e-01 | 0.002 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.943880e-01 | 0.002 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.943880e-01 | 0.002 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.945578e-01 | 0.002 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.946137e-01 | 0.002 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.947483e-01 | 0.002 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.951048e-01 | 0.002 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.954326e-01 | 0.002 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.954326e-01 | 0.002 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.956431e-01 | 0.002 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.956681e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.959977e-01 | 0.002 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.959977e-01 | 0.002 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.961612e-01 | 0.002 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.961612e-01 | 0.002 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.961612e-01 | 0.002 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.961612e-01 | 0.002 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.963466e-01 | 0.002 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.966177e-01 | 0.001 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.966177e-01 | 0.001 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.966177e-01 | 0.001 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.966662e-01 | 0.001 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.967661e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.968920e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.969109e-01 | 0.001 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.971460e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.974074e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.975196e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.975674e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.979001e-01 | 0.001 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.979202e-01 | 0.001 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.979618e-01 | 0.001 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.982042e-01 | 0.001 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.982042e-01 | 0.001 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.982042e-01 | 0.001 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.982042e-01 | 0.001 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.982342e-01 | 0.001 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.985403e-01 | 0.001 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.985717e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.986060e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.987719e-01 | 0.001 | 0 | 0 |
| The canonical retinoid cycle in rods (twilight vision) | R-HSA-2453902 | 9.987719e-01 | 0.001 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.989136e-01 | 0.000 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.989180e-01 | 0.000 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.989180e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.990023e-01 | 0.000 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.990272e-01 | 0.000 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.990467e-01 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.990467e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.991602e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.992058e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.992225e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.992601e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.992920e-01 | 0.000 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.992920e-01 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.993198e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.993267e-01 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.993700e-01 | 0.000 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.994257e-01 | 0.000 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.994257e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.994257e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.994379e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.994880e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.994987e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.995234e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.995543e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.996021e-01 | 0.000 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.996074e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.996541e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.997315e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.997771e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.997771e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.997917e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.998016e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.998069e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998145e-01 | 0.000 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.998165e-01 | 0.000 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.998198e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.998228e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.998383e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.998892e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.998895e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999000e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999233e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.999245e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.999545e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.999545e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999545e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999599e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999647e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.999689e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999689e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999726e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.999726e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999736e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999810e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999835e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999855e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999872e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.999880e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999880e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999891e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999904e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999941e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999947e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999964e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999972e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999973e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999978e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999981e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999986e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999990e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999993e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999995e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999999e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.132427e-14 | 13.946 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.350342e-13 | 12.629 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 8.196777e-13 | 12.086 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.708378e-11 | 10.567 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.232690e-10 | 9.373 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.972964e-10 | 9.303 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.213711e-09 | 8.655 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.123056e-09 | 8.673 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.198688e-09 | 8.377 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.133081e-09 | 8.384 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.916261e-09 | 8.160 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 7.301051e-09 | 8.137 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.320853e-08 | 7.879 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.326026e-08 | 7.877 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.589767e-08 | 7.799 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.025003e-08 | 7.694 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.776530e-08 | 7.556 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.210450e-07 | 6.917 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.344584e-07 | 6.871 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.228012e-07 | 6.491 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.228012e-07 | 6.491 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.228012e-07 | 6.491 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.961426e-07 | 6.528 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.228012e-07 | 6.491 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.855370e-07 | 6.544 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.654582e-07 | 6.576 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.276286e-07 | 6.369 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 4.157888e-07 | 6.381 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.287553e-07 | 6.368 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.855681e-07 | 6.314 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.859848e-07 | 6.313 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 4.808887e-07 | 6.318 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 7.374934e-07 | 6.132 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.055703e-06 | 5.976 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.050100e-06 | 5.979 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.103266e-06 | 5.957 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.210715e-06 | 5.917 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.177229e-06 | 5.929 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.221081e-06 | 5.913 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.405557e-06 | 5.852 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.411638e-06 | 5.850 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.405225e-06 | 5.852 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.109584e-06 | 5.676 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.430142e-06 | 5.614 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.564012e-06 | 5.591 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.521962e-06 | 5.598 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.844080e-06 | 5.546 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.461275e-06 | 5.461 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 4.136295e-06 | 5.383 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.294628e-06 | 5.276 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 5.872003e-06 | 5.231 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 6.130960e-06 | 5.212 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 6.549294e-06 | 5.184 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 7.076547e-06 | 5.150 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 8.338537e-06 | 5.079 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 8.338537e-06 | 5.079 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 8.724631e-06 | 5.059 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.141019e-05 | 4.943 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.218423e-05 | 4.914 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.353435e-05 | 4.869 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.546069e-05 | 4.811 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.700336e-05 | 4.769 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.700336e-05 | 4.769 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.121816e-05 | 4.673 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.132513e-05 | 4.671 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.187703e-05 | 4.660 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.505796e-05 | 4.601 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.646902e-05 | 4.438 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.925003e-05 | 4.406 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 4.701302e-05 | 4.328 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.739981e-05 | 4.324 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.168149e-05 | 4.287 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 5.587169e-05 | 4.253 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 6.698189e-05 | 4.174 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 6.866519e-05 | 4.163 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.871197e-05 | 4.163 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 7.884740e-05 | 4.103 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 8.189134e-05 | 4.087 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 7.937655e-05 | 4.100 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.606281e-05 | 4.017 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 9.729409e-05 | 4.012 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.739574e-05 | 4.011 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.063647e-04 | 3.973 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.137723e-04 | 3.944 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.175671e-04 | 3.930 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.271886e-04 | 3.896 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.277383e-04 | 3.894 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.461051e-04 | 3.835 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.464033e-04 | 3.834 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.499610e-04 | 3.824 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.601521e-04 | 3.795 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.686682e-04 | 3.773 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.808812e-04 | 3.743 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.853441e-04 | 3.732 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.853441e-04 | 3.732 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.914090e-04 | 3.718 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.222737e-04 | 3.653 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.247993e-04 | 3.648 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.271309e-04 | 3.644 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.614675e-04 | 3.583 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.658817e-04 | 3.575 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.616403e-04 | 3.582 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.564245e-04 | 3.591 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.577801e-04 | 3.589 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.750323e-04 | 3.561 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.778315e-04 | 3.556 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.212791e-04 | 3.493 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.125342e-04 | 3.505 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.093973e-04 | 3.509 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.213047e-04 | 3.493 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 3.063828e-04 | 3.514 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 3.282438e-04 | 3.484 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 3.282438e-04 | 3.484 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 3.451031e-04 | 3.462 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.448813e-04 | 3.352 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.606343e-04 | 3.337 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.606343e-04 | 3.337 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.737900e-04 | 3.241 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 5.800298e-04 | 3.237 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.841607e-04 | 3.233 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.899705e-04 | 3.229 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 7.090720e-04 | 3.149 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.258769e-04 | 3.139 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 7.090720e-04 | 3.149 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.313782e-04 | 3.136 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.090720e-04 | 3.149 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.393166e-04 | 3.131 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 7.446635e-04 | 3.128 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 8.250872e-04 | 3.084 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 8.555287e-04 | 3.068 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 8.555287e-04 | 3.068 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 8.847094e-04 | 3.053 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 9.193605e-04 | 3.037 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.333604e-04 | 3.030 | 1 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 9.362158e-04 | 3.029 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.096786e-03 | 2.960 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.096786e-03 | 2.960 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.081313e-03 | 2.966 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.020375e-03 | 2.991 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.144658e-03 | 2.941 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.166037e-03 | 2.933 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.245251e-03 | 2.905 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.245762e-03 | 2.905 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.309506e-03 | 2.883 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.439656e-03 | 2.842 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.453981e-03 | 2.837 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.456899e-03 | 2.837 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.575931e-03 | 2.802 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.615630e-03 | 2.792 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.657855e-03 | 2.780 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.693006e-03 | 2.771 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.757464e-03 | 2.755 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.822691e-03 | 2.739 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.827357e-03 | 2.738 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.910919e-03 | 2.719 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.910919e-03 | 2.719 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.246542e-03 | 2.648 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.404407e-03 | 2.619 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.411848e-03 | 2.618 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.422982e-03 | 2.616 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.692279e-03 | 2.570 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.785577e-03 | 2.555 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.785577e-03 | 2.555 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 3.099655e-03 | 2.509 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.969801e-03 | 2.527 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.831651e-03 | 2.548 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.034050e-03 | 2.518 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.170262e-03 | 2.499 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.187558e-03 | 2.497 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.214810e-03 | 2.493 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.411564e-03 | 2.467 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.423704e-03 | 2.466 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.585874e-03 | 2.445 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.593871e-03 | 2.444 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 3.918620e-03 | 2.407 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.958157e-03 | 2.403 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.958423e-03 | 2.402 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.958423e-03 | 2.402 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.111325e-03 | 2.386 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.568706e-03 | 2.340 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.274300e-03 | 2.369 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 4.752626e-03 | 2.323 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.752626e-03 | 2.323 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.623968e-03 | 2.335 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.568706e-03 | 2.340 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.708946e-03 | 2.327 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.942829e-03 | 2.306 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.942829e-03 | 2.306 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 5.057555e-03 | 2.296 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.087293e-03 | 2.294 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.252936e-03 | 2.280 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.253278e-03 | 2.280 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.253278e-03 | 2.280 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.731097e-03 | 2.242 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.763607e-03 | 2.239 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 6.130572e-03 | 2.212 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.527959e-03 | 2.185 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 6.689239e-03 | 2.175 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.893503e-03 | 2.162 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.024961e-03 | 2.153 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 7.055593e-03 | 2.151 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.055593e-03 | 2.151 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.055593e-03 | 2.151 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 8.068815e-03 | 2.093 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 7.406613e-03 | 2.130 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 7.406613e-03 | 2.130 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.865198e-03 | 2.104 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.076609e-03 | 2.093 | 0 | 0 |
| S Phase | R-HSA-69242 | 7.132636e-03 | 2.147 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.406613e-03 | 2.130 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.333919e-03 | 2.135 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 8.510275e-03 | 2.070 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.684623e-03 | 2.061 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.012466e-03 | 2.045 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.133545e-03 | 2.039 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.135009e-03 | 2.039 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.227188e-03 | 2.035 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.244523e-03 | 2.034 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 9.498894e-03 | 2.022 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 9.498894e-03 | 2.022 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 9.498894e-03 | 2.022 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 9.878882e-03 | 2.005 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.941755e-03 | 2.003 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 9.979907e-03 | 2.001 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.010251e-02 | 1.996 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.030518e-02 | 1.987 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.030518e-02 | 1.987 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.030518e-02 | 1.987 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.030518e-02 | 1.987 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.030518e-02 | 1.987 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.030518e-02 | 1.987 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.030518e-02 | 1.987 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.030518e-02 | 1.987 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.030518e-02 | 1.987 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.030518e-02 | 1.987 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.030518e-02 | 1.987 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.052183e-02 | 1.978 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.136192e-02 | 1.945 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.136192e-02 | 1.945 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.136192e-02 | 1.945 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.235684e-02 | 1.908 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.235684e-02 | 1.908 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.133841e-02 | 1.945 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.107341e-02 | 1.956 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.241235e-02 | 1.906 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.257838e-02 | 1.900 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.257838e-02 | 1.900 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.259676e-02 | 1.900 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.266929e-02 | 1.897 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.276115e-02 | 1.894 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.282342e-02 | 1.892 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.282342e-02 | 1.892 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.291473e-02 | 1.889 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.348755e-02 | 1.870 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.375098e-02 | 1.862 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.413681e-02 | 1.850 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.485660e-02 | 1.828 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.493757e-02 | 1.826 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.493757e-02 | 1.826 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.501347e-02 | 1.824 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.558494e-02 | 1.807 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.597665e-02 | 1.797 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.666009e-02 | 1.778 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.718986e-02 | 1.765 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.740199e-02 | 1.759 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.747049e-02 | 1.758 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.102101e-02 | 1.677 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.102101e-02 | 1.677 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.102101e-02 | 1.677 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.102101e-02 | 1.677 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.102101e-02 | 1.677 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.857121e-02 | 1.731 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 2.067250e-02 | 1.685 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.019156e-02 | 1.695 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.019156e-02 | 1.695 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.862840e-02 | 1.730 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.803159e-02 | 1.744 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.028378e-02 | 1.693 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.853422e-02 | 1.732 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.048851e-02 | 1.688 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.909803e-02 | 1.719 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.021194e-02 | 1.694 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.019156e-02 | 1.695 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.777867e-02 | 1.750 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.968605e-02 | 1.706 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.952188e-02 | 1.709 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.036625e-02 | 1.691 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.114567e-02 | 1.675 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.206962e-02 | 1.656 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.230787e-02 | 1.652 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.259569e-02 | 1.646 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.292742e-02 | 1.640 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.325478e-02 | 1.633 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.361876e-02 | 1.627 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.371740e-02 | 1.625 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 2.411130e-02 | 1.618 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.480883e-02 | 1.605 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.504101e-02 | 1.601 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.504322e-02 | 1.601 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.591278e-02 | 1.586 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.591278e-02 | 1.586 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.591278e-02 | 1.586 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.612800e-02 | 1.583 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.631718e-02 | 1.580 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.661534e-02 | 1.575 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.713829e-02 | 1.566 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.715568e-02 | 1.566 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.744959e-02 | 1.561 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.774737e-02 | 1.557 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.830565e-02 | 1.548 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.962462e-02 | 1.528 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.997121e-02 | 1.523 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 3.075321e-02 | 1.512 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.075321e-02 | 1.512 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.143387e-02 | 1.503 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.157351e-02 | 1.501 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.157351e-02 | 1.501 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.227839e-02 | 1.491 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.235011e-02 | 1.490 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.235011e-02 | 1.490 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.243719e-02 | 1.489 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.285334e-02 | 1.483 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.382832e-02 | 1.471 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.610893e-02 | 1.442 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.107136e-02 | 1.386 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.435092e-02 | 1.464 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.875410e-02 | 1.412 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.875410e-02 | 1.412 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.630504e-02 | 1.440 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.630504e-02 | 1.440 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.167883e-02 | 1.380 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.167883e-02 | 1.380 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.842660e-02 | 1.415 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.842660e-02 | 1.415 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.800911e-02 | 1.420 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.759019e-02 | 1.425 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.895423e-02 | 1.409 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.230790e-02 | 1.374 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 4.254648e-02 | 1.371 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.017225e-02 | 1.396 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.487045e-02 | 1.458 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.875410e-02 | 1.412 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.988174e-02 | 1.399 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.800911e-02 | 1.420 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.630504e-02 | 1.440 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.305763e-02 | 1.366 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.389326e-02 | 1.358 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.402321e-02 | 1.356 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.439376e-02 | 1.353 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.509025e-02 | 1.346 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.541026e-02 | 1.343 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 4.541026e-02 | 1.343 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 4.623182e-02 | 1.335 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.645615e-02 | 1.333 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 4.919578e-02 | 1.308 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.961368e-02 | 1.304 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.087836e-02 | 1.293 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 5.122923e-02 | 1.290 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.137613e-02 | 1.289 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.137613e-02 | 1.289 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.137613e-02 | 1.289 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 5.327423e-02 | 1.273 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.372285e-02 | 1.270 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 5.424948e-02 | 1.266 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 5.528548e-02 | 1.257 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.567313e-02 | 1.254 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 5.587442e-02 | 1.253 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 5.587442e-02 | 1.253 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 5.587442e-02 | 1.253 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 5.753298e-02 | 1.240 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 5.753298e-02 | 1.240 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 5.770546e-02 | 1.239 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 5.825870e-02 | 1.235 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.864869e-02 | 1.232 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.864869e-02 | 1.232 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.891158e-02 | 1.230 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.904226e-02 | 1.229 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.964279e-02 | 1.224 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.983856e-02 | 1.223 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.983856e-02 | 1.223 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.993260e-02 | 1.222 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.993260e-02 | 1.222 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.060036e-02 | 1.218 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 6.129774e-02 | 1.213 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.157038e-02 | 1.211 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.157038e-02 | 1.211 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.157038e-02 | 1.211 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.486283e-02 | 1.188 | 1 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 6.504640e-02 | 1.187 | 0 | 0 |
| Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK) | R-HSA-1299308 | 7.289682e-02 | 1.137 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 7.889571e-02 | 1.103 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 7.889571e-02 | 1.103 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.121072e-02 | 1.147 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 7.300392e-02 | 1.137 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 7.300392e-02 | 1.137 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 7.300392e-02 | 1.137 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 8.551287e-02 | 1.068 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.605396e-02 | 1.065 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.605396e-02 | 1.065 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 7.088801e-02 | 1.149 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.336050e-02 | 1.135 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 7.336050e-02 | 1.135 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.056143e-02 | 1.094 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.056143e-02 | 1.094 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.322033e-02 | 1.135 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 7.322033e-02 | 1.135 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.322033e-02 | 1.135 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 6.657829e-02 | 1.177 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 7.993297e-02 | 1.097 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.993297e-02 | 1.097 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.677732e-02 | 1.175 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 8.467173e-02 | 1.072 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.701739e-02 | 1.060 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.847947e-02 | 1.164 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.134406e-02 | 1.090 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 8.366274e-02 | 1.077 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.958622e-02 | 1.157 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 8.551287e-02 | 1.068 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 8.551287e-02 | 1.068 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 6.659530e-02 | 1.177 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 7.300392e-02 | 1.137 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 8.639053e-02 | 1.064 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 8.140254e-02 | 1.089 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 8.153079e-02 | 1.089 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 8.639053e-02 | 1.064 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.088801e-02 | 1.149 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 7.923262e-02 | 1.101 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 8.056143e-02 | 1.094 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.414357e-02 | 1.130 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 7.638004e-02 | 1.117 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 7.088801e-02 | 1.149 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.913209e-02 | 1.160 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 8.089303e-02 | 1.092 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.818186e-02 | 1.055 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.866790e-02 | 1.052 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.866790e-02 | 1.052 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.866790e-02 | 1.052 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.178377e-02 | 1.037 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.220957e-02 | 1.035 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.220957e-02 | 1.035 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.233657e-02 | 1.035 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 9.288414e-02 | 1.032 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.288414e-02 | 1.032 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.288414e-02 | 1.032 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.447440e-02 | 1.025 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 9.484796e-02 | 1.023 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 9.530801e-02 | 1.021 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 9.540349e-02 | 1.020 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.582271e-02 | 1.019 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.583738e-02 | 1.018 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 9.672906e-02 | 1.014 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 9.759820e-02 | 1.011 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 9.906858e-02 | 1.004 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 9.906858e-02 | 1.004 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 9.906858e-02 | 1.004 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.938502e-02 | 1.003 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.938502e-02 | 1.003 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.954286e-02 | 1.002 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 1.001122e-01 | 1.000 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 1.001122e-01 | 1.000 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.001122e-01 | 1.000 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.001122e-01 | 1.000 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 1.001122e-01 | 1.000 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.001122e-01 | 1.000 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.018002e-01 | 0.992 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.023035e-01 | 0.990 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.023035e-01 | 0.990 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.029983e-01 | 0.987 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.029983e-01 | 0.987 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.029983e-01 | 0.987 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.029983e-01 | 0.987 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.038138e-01 | 0.984 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.038138e-01 | 0.984 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.044287e-01 | 0.981 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.044287e-01 | 0.981 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.050420e-01 | 0.979 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.058308e-01 | 0.975 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 1.061661e-01 | 0.974 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 1.061661e-01 | 0.974 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.061661e-01 | 0.974 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 1.061661e-01 | 0.974 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.065478e-01 | 0.972 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.073836e-01 | 0.969 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.073836e-01 | 0.969 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.073836e-01 | 0.969 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.076102e-01 | 0.968 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.078582e-01 | 0.967 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.100664e-01 | 0.958 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.100806e-01 | 0.958 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.108387e-01 | 0.955 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.108387e-01 | 0.955 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.136320e-01 | 0.944 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.136320e-01 | 0.944 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.136320e-01 | 0.944 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.136320e-01 | 0.944 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.156900e-01 | 0.937 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.161953e-01 | 0.935 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.179814e-01 | 0.928 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.190150e-01 | 0.924 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.190150e-01 | 0.924 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.209425e-01 | 0.917 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.209425e-01 | 0.917 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.214558e-01 | 0.916 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.218729e-01 | 0.914 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.228331e-01 | 0.911 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 1.233270e-01 | 0.909 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.233270e-01 | 0.909 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.233270e-01 | 0.909 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.242455e-01 | 0.906 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.268824e-01 | 0.897 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.425991e-01 | 0.846 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.425991e-01 | 0.846 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.425991e-01 | 0.846 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.425991e-01 | 0.846 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.811732e-01 | 0.742 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.811732e-01 | 0.742 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.811732e-01 | 0.742 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.482696e-01 | 0.829 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.604086e-01 | 0.795 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 1.455802e-01 | 0.837 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 1.816920e-01 | 0.741 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.816920e-01 | 0.741 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.628456e-01 | 0.788 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.628456e-01 | 0.788 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.628456e-01 | 0.788 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.808823e-01 | 0.743 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.611759e-01 | 0.793 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.932250e-01 | 0.714 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.529444e-01 | 0.815 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.325172e-01 | 0.878 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.478686e-01 | 0.830 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.409420e-01 | 0.851 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.597108e-01 | 0.797 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.473951e-01 | 0.832 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.325172e-01 | 0.878 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.597108e-01 | 0.797 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.575476e-01 | 0.803 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.796779e-01 | 0.746 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.604086e-01 | 0.795 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.441205e-01 | 0.841 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.785544e-01 | 0.748 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.597108e-01 | 0.797 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.711373e-01 | 0.767 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.746650e-01 | 0.758 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.441205e-01 | 0.841 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.860094e-01 | 0.730 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.425991e-01 | 0.846 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.482696e-01 | 0.829 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 1.611759e-01 | 0.793 | 0 | 0 |
| Translation | R-HSA-72766 | 1.297027e-01 | 0.887 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 1.811732e-01 | 0.742 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.482696e-01 | 0.829 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.529444e-01 | 0.815 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.932250e-01 | 0.714 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.409420e-01 | 0.851 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.820101e-01 | 0.740 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 1.425991e-01 | 0.846 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.408469e-01 | 0.851 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 1.592974e-01 | 0.798 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.417993e-01 | 0.848 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.303981e-01 | 0.885 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.913447e-01 | 0.718 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 1.604086e-01 | 0.795 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.482696e-01 | 0.829 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.769047e-01 | 0.752 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.469193e-01 | 0.833 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.833714e-01 | 0.737 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.833714e-01 | 0.737 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.864928e-01 | 0.729 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.750928e-01 | 0.757 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 1.729077e-01 | 0.762 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.604086e-01 | 0.795 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.604086e-01 | 0.795 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.529444e-01 | 0.815 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 1.746650e-01 | 0.758 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.874688e-01 | 0.727 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.746650e-01 | 0.758 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 1.425991e-01 | 0.846 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.441205e-01 | 0.841 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.441205e-01 | 0.841 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.441205e-01 | 0.841 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.460847e-01 | 0.835 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.711373e-01 | 0.767 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.746650e-01 | 0.758 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.409420e-01 | 0.851 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.655208e-01 | 0.781 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.316737e-01 | 0.881 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.291546e-01 | 0.889 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.361522e-01 | 0.866 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.750928e-01 | 0.757 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.963591e-01 | 0.707 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.979575e-01 | 0.703 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.979575e-01 | 0.703 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 1.979575e-01 | 0.703 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.979575e-01 | 0.703 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.979575e-01 | 0.703 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.979575e-01 | 0.703 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 1.979575e-01 | 0.703 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 1.979575e-01 | 0.703 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.979575e-01 | 0.703 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 1.996176e-01 | 0.700 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.996176e-01 | 0.700 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.009798e-01 | 0.697 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.009798e-01 | 0.697 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 2.009798e-01 | 0.697 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.009798e-01 | 0.697 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 2.022412e-01 | 0.694 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.022412e-01 | 0.694 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 2.022412e-01 | 0.694 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 2.022412e-01 | 0.694 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.038409e-01 | 0.691 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.058974e-01 | 0.686 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.058974e-01 | 0.686 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.083917e-01 | 0.681 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.100880e-01 | 0.678 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.100880e-01 | 0.678 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 2.107058e-01 | 0.676 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.107058e-01 | 0.676 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.118324e-01 | 0.674 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.158314e-01 | 0.666 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.163967e-01 | 0.665 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.177499e-01 | 0.662 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.177499e-01 | 0.662 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.189757e-01 | 0.660 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.189757e-01 | 0.660 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.193835e-01 | 0.659 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.201544e-01 | 0.657 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 2.201544e-01 | 0.657 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 2.210444e-01 | 0.656 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.210444e-01 | 0.656 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 2.210444e-01 | 0.656 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.210444e-01 | 0.656 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 2.210444e-01 | 0.656 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.210444e-01 | 0.656 | 0 | 0 |
| Proton/oligopeptide cotransporters | R-HSA-427975 | 2.210444e-01 | 0.656 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.210444e-01 | 0.656 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.220274e-01 | 0.654 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 2.222454e-01 | 0.653 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 2.267263e-01 | 0.644 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.267263e-01 | 0.644 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.267263e-01 | 0.644 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.274425e-01 | 0.643 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 2.293232e-01 | 0.640 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 2.299541e-01 | 0.638 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 2.307354e-01 | 0.637 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 2.307354e-01 | 0.637 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.817236e-01 | 0.550 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 2.817236e-01 | 0.550 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.817236e-01 | 0.550 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.817236e-01 | 0.550 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.817236e-01 | 0.550 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.817236e-01 | 0.550 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.817236e-01 | 0.550 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.817236e-01 | 0.550 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.817236e-01 | 0.550 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.567455e-01 | 0.448 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.567455e-01 | 0.448 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.567455e-01 | 0.448 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.567455e-01 | 0.448 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.567455e-01 | 0.448 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 2.615218e-01 | 0.582 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.615218e-01 | 0.582 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.020442e-01 | 0.520 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 3.020442e-01 | 0.520 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.020442e-01 | 0.520 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.020442e-01 | 0.520 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.239355e-01 | 0.373 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.239355e-01 | 0.373 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 4.239355e-01 | 0.373 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.239355e-01 | 0.373 | 0 | 0 |
| Defective HPRT1 disrupts guanine and hypoxanthine salvage | R-HSA-9734281 | 4.239355e-01 | 0.373 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.598987e-01 | 0.585 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.421610e-01 | 0.466 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 3.421610e-01 | 0.466 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 3.421610e-01 | 0.466 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.421610e-01 | 0.466 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.894985e-01 | 0.538 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 2.894985e-01 | 0.538 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.894985e-01 | 0.538 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.894985e-01 | 0.538 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.894985e-01 | 0.538 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.502192e-01 | 0.602 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.388789e-01 | 0.622 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.741932e-01 | 0.562 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.741932e-01 | 0.562 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.741932e-01 | 0.562 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.815152e-01 | 0.418 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.815152e-01 | 0.418 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.815152e-01 | 0.418 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 3.815152e-01 | 0.418 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.815152e-01 | 0.418 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.985252e-01 | 0.525 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.985252e-01 | 0.525 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.985252e-01 | 0.525 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.985252e-01 | 0.525 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.491714e-01 | 0.457 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.800060e-01 | 0.553 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 4.198286e-01 | 0.377 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.198286e-01 | 0.377 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 2.484205e-01 | 0.605 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 3.477971e-01 | 0.459 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.477971e-01 | 0.459 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.223740e-01 | 0.492 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.438340e-01 | 0.464 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.438340e-01 | 0.464 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.725194e-01 | 0.429 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 4.082781e-01 | 0.389 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 2.783282e-01 | 0.555 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.653817e-01 | 0.437 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 3.971661e-01 | 0.401 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 3.971661e-01 | 0.401 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 4.372439e-01 | 0.359 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.775470e-01 | 0.423 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.216465e-01 | 0.375 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.216465e-01 | 0.375 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.121658e-01 | 0.506 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.656559e-01 | 0.332 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.458722e-01 | 0.461 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 4.458779e-01 | 0.351 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.458779e-01 | 0.351 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.760145e-01 | 0.425 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.428882e-01 | 0.354 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 4.406918e-01 | 0.356 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.439811e-01 | 0.613 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 4.547018e-01 | 0.342 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.649496e-01 | 0.577 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.649496e-01 | 0.577 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.438340e-01 | 0.464 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.502192e-01 | 0.602 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.800060e-01 | 0.553 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.396993e-01 | 0.357 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.366325e-01 | 0.360 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.634143e-01 | 0.579 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.452359e-01 | 0.610 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.688358e-01 | 0.433 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 3.511611e-01 | 0.454 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.815152e-01 | 0.418 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.198286e-01 | 0.377 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.688358e-01 | 0.433 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.649496e-01 | 0.577 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 3.725194e-01 | 0.429 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.858356e-01 | 0.544 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.800060e-01 | 0.553 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.007090e-01 | 0.522 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 3.688358e-01 | 0.433 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.388935e-01 | 0.470 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 2.598987e-01 | 0.585 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 2.598987e-01 | 0.585 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.741932e-01 | 0.562 | 0 | 0 |
| PKA activation | R-HSA-163615 | 4.656559e-01 | 0.332 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 4.656559e-01 | 0.332 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.458779e-01 | 0.351 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 3.602645e-01 | 0.443 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 3.066365e-01 | 0.513 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.421610e-01 | 0.466 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 2.817703e-01 | 0.550 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.971661e-01 | 0.401 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.173966e-01 | 0.498 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.298857e-01 | 0.367 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.572804e-01 | 0.340 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.969242e-01 | 0.401 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 2.819235e-01 | 0.550 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 2.901417e-01 | 0.537 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 3.010732e-01 | 0.521 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.800060e-01 | 0.553 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.598987e-01 | 0.585 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.598987e-01 | 0.585 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.598987e-01 | 0.585 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.421610e-01 | 0.466 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 2.985252e-01 | 0.525 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 4.198286e-01 | 0.377 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 3.421610e-01 | 0.466 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.601130e-01 | 0.337 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 4.216465e-01 | 0.375 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.634143e-01 | 0.579 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.615218e-01 | 0.582 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.421610e-01 | 0.466 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.741932e-01 | 0.562 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.347646e-01 | 0.629 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 4.082781e-01 | 0.389 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.581871e-01 | 0.446 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.248253e-01 | 0.488 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.020442e-01 | 0.520 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 2.988422e-01 | 0.525 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.741932e-01 | 0.562 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 2.598987e-01 | 0.585 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.725194e-01 | 0.429 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.331749e-01 | 0.477 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.547018e-01 | 0.342 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.817236e-01 | 0.550 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.567455e-01 | 0.448 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.567455e-01 | 0.448 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.239355e-01 | 0.373 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 3.421610e-01 | 0.466 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.741932e-01 | 0.562 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.815152e-01 | 0.418 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.568895e-01 | 0.340 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.568895e-01 | 0.340 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.458779e-01 | 0.351 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 4.458779e-01 | 0.351 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.718287e-01 | 0.430 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.298857e-01 | 0.367 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.044193e-01 | 0.517 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.988422e-01 | 0.525 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.197167e-01 | 0.495 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 4.366325e-01 | 0.360 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 3.421610e-01 | 0.466 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 3.526417e-01 | 0.453 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.708328e-01 | 0.567 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.899547e-01 | 0.538 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 4.012154e-01 | 0.397 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.865635e-01 | 0.413 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.458680e-01 | 0.351 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.815152e-01 | 0.418 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.198286e-01 | 0.377 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.536409e-01 | 0.596 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 3.862822e-01 | 0.413 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.615218e-01 | 0.582 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 2.741932e-01 | 0.562 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.815152e-01 | 0.418 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 3.815152e-01 | 0.418 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.815152e-01 | 0.418 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.985252e-01 | 0.525 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 2.988422e-01 | 0.525 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 2.988422e-01 | 0.525 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 4.082781e-01 | 0.389 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 3.602645e-01 | 0.443 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.837672e-01 | 0.416 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.817703e-01 | 0.550 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.552578e-01 | 0.593 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.407434e-01 | 0.618 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.020442e-01 | 0.520 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.683901e-01 | 0.434 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 3.683901e-01 | 0.434 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.038071e-01 | 0.394 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 3.971661e-01 | 0.401 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.183744e-01 | 0.378 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.498570e-01 | 0.456 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.321441e-01 | 0.479 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.644186e-01 | 0.333 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 2.817236e-01 | 0.550 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.615218e-01 | 0.582 | 0 | 0 |
| SLC-mediated transport of oligopeptides | R-HSA-9959399 | 3.020442e-01 | 0.520 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 4.239355e-01 | 0.373 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 4.239355e-01 | 0.373 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.452359e-01 | 0.610 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 2.452359e-01 | 0.610 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.198286e-01 | 0.377 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 3.788754e-01 | 0.422 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 2.649496e-01 | 0.577 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.197167e-01 | 0.495 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.197167e-01 | 0.495 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 4.162718e-01 | 0.381 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 3.688358e-01 | 0.433 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.307102e-01 | 0.481 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 2.894985e-01 | 0.538 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.511372e-01 | 0.346 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.198286e-01 | 0.377 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 2.484205e-01 | 0.605 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.568895e-01 | 0.340 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 4.644186e-01 | 0.333 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.183744e-01 | 0.378 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.985018e-01 | 0.525 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 3.567455e-01 | 0.448 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 3.020442e-01 | 0.520 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.020442e-01 | 0.520 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 4.239355e-01 | 0.373 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.198286e-01 | 0.377 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 2.484205e-01 | 0.605 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.388935e-01 | 0.470 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.581871e-01 | 0.446 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.581871e-01 | 0.446 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.989242e-01 | 0.524 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 4.656559e-01 | 0.332 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.578301e-01 | 0.589 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.568895e-01 | 0.340 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.963075e-01 | 0.402 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 3.747317e-01 | 0.426 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.567455e-01 | 0.448 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 3.020442e-01 | 0.520 | 0 | 0 |
| Expression and Processing of Neurotrophins | R-HSA-9036866 | 4.239355e-01 | 0.373 | 0 | 0 |
| NGF processing | R-HSA-167060 | 4.239355e-01 | 0.373 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 3.193209e-01 | 0.496 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.815152e-01 | 0.418 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 2.819235e-01 | 0.550 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.007090e-01 | 0.522 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.007090e-01 | 0.522 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.477971e-01 | 0.459 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 3.688358e-01 | 0.433 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 3.688358e-01 | 0.433 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 4.220305e-01 | 0.375 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 4.198286e-01 | 0.377 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 4.082781e-01 | 0.389 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.568895e-01 | 0.340 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 2.894985e-01 | 0.538 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.653817e-01 | 0.437 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 4.656559e-01 | 0.332 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 4.372439e-01 | 0.359 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 3.193209e-01 | 0.496 | 0 | 0 |
| Synthesis and processing of ENV and VPU | R-HSA-171286 | 3.567455e-01 | 0.448 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 3.969242e-01 | 0.401 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 4.302896e-01 | 0.366 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.697853e-01 | 0.328 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 4.697853e-01 | 0.328 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.697853e-01 | 0.328 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 4.697853e-01 | 0.328 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 4.697853e-01 | 0.328 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 4.697853e-01 | 0.328 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 4.721722e-01 | 0.326 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 4.721722e-01 | 0.326 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.721722e-01 | 0.326 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.721722e-01 | 0.326 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.721722e-01 | 0.326 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.721722e-01 | 0.326 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.747423e-01 | 0.324 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.747423e-01 | 0.324 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.747423e-01 | 0.324 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 4.763843e-01 | 0.322 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.771264e-01 | 0.321 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 4.838320e-01 | 0.315 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.841108e-01 | 0.315 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.841108e-01 | 0.315 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.841108e-01 | 0.315 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.841108e-01 | 0.315 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.841108e-01 | 0.315 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.841108e-01 | 0.315 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 4.841108e-01 | 0.315 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.841108e-01 | 0.315 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.841108e-01 | 0.315 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.841108e-01 | 0.315 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.841108e-01 | 0.315 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 4.887612e-01 | 0.311 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.895134e-01 | 0.310 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.916036e-01 | 0.308 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.925415e-01 | 0.308 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.925415e-01 | 0.308 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.925415e-01 | 0.308 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.925415e-01 | 0.308 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.925415e-01 | 0.308 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.925415e-01 | 0.308 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.925415e-01 | 0.308 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 4.929420e-01 | 0.307 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.929420e-01 | 0.307 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.933016e-01 | 0.307 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 4.933016e-01 | 0.307 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 4.933016e-01 | 0.307 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.933016e-01 | 0.307 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.933016e-01 | 0.307 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 4.934144e-01 | 0.307 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 4.934144e-01 | 0.307 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 4.934144e-01 | 0.307 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 4.934144e-01 | 0.307 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 4.934144e-01 | 0.307 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.952804e-01 | 0.305 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.049779e-01 | 0.297 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.049779e-01 | 0.297 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.075903e-01 | 0.294 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.110863e-01 | 0.292 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.110863e-01 | 0.292 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.134022e-01 | 0.290 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.134022e-01 | 0.290 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.163675e-01 | 0.287 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 5.191125e-01 | 0.285 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 5.204361e-01 | 0.284 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 5.204361e-01 | 0.284 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.204361e-01 | 0.284 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 5.204361e-01 | 0.284 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.266746e-01 | 0.278 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.266746e-01 | 0.278 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 5.266746e-01 | 0.278 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.266746e-01 | 0.278 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 5.266746e-01 | 0.278 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 5.266746e-01 | 0.278 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 5.266746e-01 | 0.278 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 5.266746e-01 | 0.278 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 5.266746e-01 | 0.278 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.266746e-01 | 0.278 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.266746e-01 | 0.278 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.266746e-01 | 0.278 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 5.266746e-01 | 0.278 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 5.307128e-01 | 0.275 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.331184e-01 | 0.273 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.358650e-01 | 0.271 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 5.380035e-01 | 0.269 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 5.380035e-01 | 0.269 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.380035e-01 | 0.269 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.380035e-01 | 0.269 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 5.380035e-01 | 0.269 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.380035e-01 | 0.269 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.380035e-01 | 0.269 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.380035e-01 | 0.269 | 0 | 0 |
| Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA) | R-HSA-5619067 | 5.380035e-01 | 0.269 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 5.380035e-01 | 0.269 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 5.380035e-01 | 0.269 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.380035e-01 | 0.269 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.380035e-01 | 0.269 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.380035e-01 | 0.269 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.380035e-01 | 0.269 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 5.380035e-01 | 0.269 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.380035e-01 | 0.269 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.380035e-01 | 0.269 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.380035e-01 | 0.269 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.380035e-01 | 0.269 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.380035e-01 | 0.269 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 5.380035e-01 | 0.269 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.389311e-01 | 0.268 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.389311e-01 | 0.268 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.390534e-01 | 0.268 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.393740e-01 | 0.268 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 5.466527e-01 | 0.262 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 5.466527e-01 | 0.262 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 5.466527e-01 | 0.262 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 5.474321e-01 | 0.262 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 5.474321e-01 | 0.262 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.474321e-01 | 0.262 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.532377e-01 | 0.257 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.538408e-01 | 0.257 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.544901e-01 | 0.256 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 5.592173e-01 | 0.252 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.592173e-01 | 0.252 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 5.592173e-01 | 0.252 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.592173e-01 | 0.252 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.592173e-01 | 0.252 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.592891e-01 | 0.252 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 5.592891e-01 | 0.252 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.605474e-01 | 0.251 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 5.629590e-01 | 0.250 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 5.655342e-01 | 0.248 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 5.669109e-01 | 0.246 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 5.720098e-01 | 0.243 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 5.720098e-01 | 0.243 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.720098e-01 | 0.243 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.754763e-01 | 0.240 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.785896e-01 | 0.238 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.790550e-01 | 0.237 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.823785e-01 | 0.235 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 5.823785e-01 | 0.235 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.862690e-01 | 0.232 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.862690e-01 | 0.232 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.862690e-01 | 0.232 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.862690e-01 | 0.232 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.862690e-01 | 0.232 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 5.862690e-01 | 0.232 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.862690e-01 | 0.232 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.862690e-01 | 0.232 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.862690e-01 | 0.232 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.862690e-01 | 0.232 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.862690e-01 | 0.232 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.862690e-01 | 0.232 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.862690e-01 | 0.232 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.862690e-01 | 0.232 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.862690e-01 | 0.232 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.862690e-01 | 0.232 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.862690e-01 | 0.232 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.862690e-01 | 0.232 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.901291e-01 | 0.229 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.901291e-01 | 0.229 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.901291e-01 | 0.229 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.901291e-01 | 0.229 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 5.901291e-01 | 0.229 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 5.901291e-01 | 0.229 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.901291e-01 | 0.229 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 5.954343e-01 | 0.225 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.964658e-01 | 0.224 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 5.964658e-01 | 0.224 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 5.964658e-01 | 0.224 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 5.964658e-01 | 0.224 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 5.995273e-01 | 0.222 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 6.031930e-01 | 0.220 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 6.098008e-01 | 0.215 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.098008e-01 | 0.215 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.116754e-01 | 0.213 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 6.161585e-01 | 0.210 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.161585e-01 | 0.210 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.193958e-01 | 0.208 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.193958e-01 | 0.208 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 6.193958e-01 | 0.208 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 6.193958e-01 | 0.208 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 6.193958e-01 | 0.208 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.193958e-01 | 0.208 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.193958e-01 | 0.208 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.193958e-01 | 0.208 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 6.193958e-01 | 0.208 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 6.199899e-01 | 0.208 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.199899e-01 | 0.208 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 6.199899e-01 | 0.208 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.222411e-01 | 0.206 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.222411e-01 | 0.206 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.222411e-01 | 0.206 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.222411e-01 | 0.206 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.222411e-01 | 0.206 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.233652e-01 | 0.205 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 6.233652e-01 | 0.205 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 6.233652e-01 | 0.205 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.294947e-01 | 0.201 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.294947e-01 | 0.201 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.294947e-01 | 0.201 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.294947e-01 | 0.201 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 6.294947e-01 | 0.201 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 6.294947e-01 | 0.201 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 6.294947e-01 | 0.201 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 6.294947e-01 | 0.201 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.294947e-01 | 0.201 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 6.294947e-01 | 0.201 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.294947e-01 | 0.201 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 6.294947e-01 | 0.201 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.294947e-01 | 0.201 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.294947e-01 | 0.201 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.294947e-01 | 0.201 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.294947e-01 | 0.201 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 6.294947e-01 | 0.201 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.325725e-01 | 0.199 | 0 | 0 |
| Immune System | R-HSA-168256 | 6.335099e-01 | 0.198 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.336233e-01 | 0.198 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 6.371805e-01 | 0.196 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 6.371805e-01 | 0.196 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.425620e-01 | 0.192 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 6.425620e-01 | 0.192 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 6.425620e-01 | 0.192 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 6.428754e-01 | 0.192 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 6.451025e-01 | 0.190 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 6.451025e-01 | 0.190 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.470236e-01 | 0.189 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 6.470236e-01 | 0.189 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.470236e-01 | 0.189 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.470236e-01 | 0.189 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.470236e-01 | 0.189 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.470236e-01 | 0.189 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.482189e-01 | 0.188 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.482189e-01 | 0.188 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 6.517749e-01 | 0.186 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 6.617088e-01 | 0.179 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 6.617088e-01 | 0.179 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.617088e-01 | 0.179 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 6.619809e-01 | 0.179 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.641706e-01 | 0.178 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 6.641706e-01 | 0.178 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.660144e-01 | 0.177 | 0 | 0 |
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | R-HSA-159782 | 6.682066e-01 | 0.175 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.682066e-01 | 0.175 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.682066e-01 | 0.175 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.682066e-01 | 0.175 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.682066e-01 | 0.175 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 6.682066e-01 | 0.175 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.682066e-01 | 0.175 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.682066e-01 | 0.175 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.682066e-01 | 0.175 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 6.682066e-01 | 0.175 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.682066e-01 | 0.175 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.682066e-01 | 0.175 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.717620e-01 | 0.173 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.719082e-01 | 0.173 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.730355e-01 | 0.172 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 6.730355e-01 | 0.172 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 6.730355e-01 | 0.172 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.730355e-01 | 0.172 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 6.783295e-01 | 0.169 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 6.785751e-01 | 0.168 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 6.785751e-01 | 0.168 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 6.785751e-01 | 0.168 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.798908e-01 | 0.168 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.806518e-01 | 0.167 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.848123e-01 | 0.164 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.848123e-01 | 0.164 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 6.866898e-01 | 0.163 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.931312e-01 | 0.159 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 6.933975e-01 | 0.159 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 6.944652e-01 | 0.158 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 6.973102e-01 | 0.157 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 6.973102e-01 | 0.157 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.974675e-01 | 0.156 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 6.974675e-01 | 0.156 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 6.974675e-01 | 0.156 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.974675e-01 | 0.156 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.974675e-01 | 0.156 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.974675e-01 | 0.156 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.974675e-01 | 0.156 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 7.028757e-01 | 0.153 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 7.028757e-01 | 0.153 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.028757e-01 | 0.153 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.028757e-01 | 0.153 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.028757e-01 | 0.153 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.028757e-01 | 0.153 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.028757e-01 | 0.153 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.028757e-01 | 0.153 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 7.028757e-01 | 0.153 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.028757e-01 | 0.153 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.028757e-01 | 0.153 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.028757e-01 | 0.153 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.028757e-01 | 0.153 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.028757e-01 | 0.153 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.028757e-01 | 0.153 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.028757e-01 | 0.153 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 7.028757e-01 | 0.153 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.028757e-01 | 0.153 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.028757e-01 | 0.153 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.028757e-01 | 0.153 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.028757e-01 | 0.153 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 7.044904e-01 | 0.152 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.044904e-01 | 0.152 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.044904e-01 | 0.152 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 7.044904e-01 | 0.152 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.044904e-01 | 0.152 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.044904e-01 | 0.152 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.094108e-01 | 0.149 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.094108e-01 | 0.149 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.094108e-01 | 0.149 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 7.140711e-01 | 0.146 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 7.140711e-01 | 0.146 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.203657e-01 | 0.142 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.203657e-01 | 0.142 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.203657e-01 | 0.142 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.203657e-01 | 0.142 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 7.203657e-01 | 0.142 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 7.208679e-01 | 0.142 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 7.232142e-01 | 0.141 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.232142e-01 | 0.141 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.241368e-01 | 0.140 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 7.301402e-01 | 0.137 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.301402e-01 | 0.137 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 7.301402e-01 | 0.137 | 0 | 0 |
| Depurination | R-HSA-73927 | 7.301402e-01 | 0.137 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.301402e-01 | 0.137 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 7.339240e-01 | 0.134 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.339240e-01 | 0.134 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.339240e-01 | 0.134 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.339240e-01 | 0.134 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.339240e-01 | 0.134 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.339240e-01 | 0.134 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.339240e-01 | 0.134 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.339240e-01 | 0.134 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.339240e-01 | 0.134 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.339240e-01 | 0.134 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.339240e-01 | 0.134 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.339240e-01 | 0.134 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 7.339240e-01 | 0.134 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.340642e-01 | 0.134 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 7.383190e-01 | 0.132 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.409983e-01 | 0.130 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 7.409983e-01 | 0.130 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.417838e-01 | 0.130 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.417838e-01 | 0.130 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 7.417838e-01 | 0.130 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 7.417838e-01 | 0.130 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 7.417838e-01 | 0.130 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.417838e-01 | 0.130 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.418005e-01 | 0.130 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.424580e-01 | 0.129 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.435993e-01 | 0.129 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.455226e-01 | 0.128 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 7.519598e-01 | 0.124 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.578612e-01 | 0.120 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 7.578612e-01 | 0.120 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.578612e-01 | 0.120 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 7.591115e-01 | 0.120 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 7.591115e-01 | 0.120 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.602263e-01 | 0.119 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.602263e-01 | 0.119 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.602263e-01 | 0.119 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.603824e-01 | 0.119 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.615336e-01 | 0.118 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.617296e-01 | 0.118 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.617296e-01 | 0.118 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.617296e-01 | 0.118 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.617296e-01 | 0.118 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.617296e-01 | 0.118 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 7.617296e-01 | 0.118 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.617296e-01 | 0.118 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.617296e-01 | 0.118 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.617296e-01 | 0.118 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.617296e-01 | 0.118 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.617296e-01 | 0.118 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.617810e-01 | 0.118 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 7.617810e-01 | 0.118 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.634695e-01 | 0.117 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.644484e-01 | 0.117 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.738252e-01 | 0.111 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.738252e-01 | 0.111 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 7.738252e-01 | 0.111 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.742615e-01 | 0.111 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 7.742615e-01 | 0.111 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 7.742615e-01 | 0.111 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.770030e-01 | 0.110 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 7.773180e-01 | 0.109 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.804204e-01 | 0.108 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.804204e-01 | 0.108 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.804204e-01 | 0.108 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 7.804204e-01 | 0.108 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 7.823800e-01 | 0.107 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.841183e-01 | 0.106 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.866309e-01 | 0.104 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 7.866309e-01 | 0.104 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 7.866309e-01 | 0.104 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 7.866309e-01 | 0.104 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 7.866309e-01 | 0.104 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 7.866309e-01 | 0.104 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.866309e-01 | 0.104 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.866309e-01 | 0.104 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.866309e-01 | 0.104 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.866309e-01 | 0.104 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.866309e-01 | 0.104 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.876409e-01 | 0.104 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.876409e-01 | 0.104 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.876409e-01 | 0.104 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.876409e-01 | 0.104 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 7.876409e-01 | 0.104 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.896831e-01 | 0.103 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 7.924172e-01 | 0.101 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 7.933576e-01 | 0.101 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 7.933576e-01 | 0.101 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.933981e-01 | 0.101 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 7.977673e-01 | 0.098 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.003786e-01 | 0.097 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.003786e-01 | 0.097 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.031593e-01 | 0.095 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.039050e-01 | 0.095 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.089311e-01 | 0.092 | 0 | 0 |
| Scavenging by Class H Receptors | R-HSA-3000497 | 8.089311e-01 | 0.092 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.089311e-01 | 0.092 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 8.089311e-01 | 0.092 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 8.089311e-01 | 0.092 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 8.089311e-01 | 0.092 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 8.089311e-01 | 0.092 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.089311e-01 | 0.092 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 8.089311e-01 | 0.092 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 8.089311e-01 | 0.092 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 8.089311e-01 | 0.092 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.089311e-01 | 0.092 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.089311e-01 | 0.092 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 8.089311e-01 | 0.092 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.089311e-01 | 0.092 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.122428e-01 | 0.090 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.124906e-01 | 0.090 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.124906e-01 | 0.090 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.124906e-01 | 0.090 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.138883e-01 | 0.089 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.138883e-01 | 0.089 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 8.138883e-01 | 0.089 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 8.138883e-01 | 0.089 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 8.138883e-01 | 0.089 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.163952e-01 | 0.088 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.165860e-01 | 0.088 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.200619e-01 | 0.086 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.217767e-01 | 0.085 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 8.259625e-01 | 0.083 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 8.288499e-01 | 0.082 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 8.288499e-01 | 0.082 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.289018e-01 | 0.081 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.289018e-01 | 0.081 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.289018e-01 | 0.081 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.289018e-01 | 0.081 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.289018e-01 | 0.081 | 0 | 0 |
| Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | R-HSA-159854 | 8.289018e-01 | 0.081 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.289018e-01 | 0.081 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.289018e-01 | 0.081 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.289018e-01 | 0.081 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.289018e-01 | 0.081 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.289018e-01 | 0.081 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 8.292262e-01 | 0.081 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.292262e-01 | 0.081 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.292262e-01 | 0.081 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.292262e-01 | 0.081 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.330387e-01 | 0.079 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.346132e-01 | 0.079 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.349067e-01 | 0.078 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.349067e-01 | 0.078 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.362798e-01 | 0.078 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 8.411114e-01 | 0.075 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.411114e-01 | 0.075 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.427184e-01 | 0.074 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.427184e-01 | 0.074 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.427184e-01 | 0.074 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 8.427184e-01 | 0.074 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.427184e-01 | 0.074 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 8.467861e-01 | 0.072 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 8.467861e-01 | 0.072 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.467861e-01 | 0.072 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 8.467861e-01 | 0.072 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.467861e-01 | 0.072 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 8.467861e-01 | 0.072 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.484321e-01 | 0.071 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.486719e-01 | 0.071 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.501143e-01 | 0.071 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.515278e-01 | 0.070 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.522735e-01 | 0.069 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.550373e-01 | 0.068 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 8.550373e-01 | 0.068 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.555588e-01 | 0.068 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.555588e-01 | 0.068 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.555588e-01 | 0.068 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.555588e-01 | 0.068 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.555588e-01 | 0.068 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.602072e-01 | 0.065 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 8.602072e-01 | 0.065 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.602072e-01 | 0.065 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.628021e-01 | 0.064 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.628021e-01 | 0.064 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.628021e-01 | 0.064 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 8.628021e-01 | 0.064 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.628021e-01 | 0.064 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.628021e-01 | 0.064 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.628021e-01 | 0.064 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.628021e-01 | 0.064 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.628021e-01 | 0.064 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.628021e-01 | 0.064 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.628021e-01 | 0.064 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.628021e-01 | 0.064 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.642948e-01 | 0.063 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.642948e-01 | 0.063 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 8.642948e-01 | 0.063 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.664597e-01 | 0.062 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.674345e-01 | 0.062 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.684573e-01 | 0.061 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.728464e-01 | 0.059 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.763741e-01 | 0.057 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.771446e-01 | 0.057 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.771446e-01 | 0.057 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 8.771446e-01 | 0.057 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 8.771446e-01 | 0.057 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.771446e-01 | 0.057 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.771446e-01 | 0.057 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.771446e-01 | 0.057 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.771446e-01 | 0.057 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.771446e-01 | 0.057 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.771446e-01 | 0.057 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.771446e-01 | 0.057 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 8.784067e-01 | 0.056 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.784067e-01 | 0.056 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.784067e-01 | 0.056 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.812954e-01 | 0.055 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 8.817446e-01 | 0.055 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.854429e-01 | 0.053 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 8.859463e-01 | 0.053 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.885345e-01 | 0.051 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.885345e-01 | 0.051 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 8.897478e-01 | 0.051 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.899886e-01 | 0.051 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.899886e-01 | 0.051 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.899886e-01 | 0.051 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.899886e-01 | 0.051 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.899886e-01 | 0.051 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 8.899886e-01 | 0.051 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.899886e-01 | 0.051 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 8.899886e-01 | 0.051 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.899886e-01 | 0.051 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.899886e-01 | 0.051 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.899886e-01 | 0.051 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.899886e-01 | 0.051 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 8.899886e-01 | 0.051 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 8.899886e-01 | 0.051 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.899886e-01 | 0.051 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.899886e-01 | 0.051 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 8.899886e-01 | 0.051 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.903365e-01 | 0.050 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.920604e-01 | 0.050 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.966136e-01 | 0.047 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.978746e-01 | 0.047 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.978746e-01 | 0.047 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.978746e-01 | 0.047 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.978746e-01 | 0.047 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.978746e-01 | 0.047 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.983646e-01 | 0.047 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.983646e-01 | 0.047 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.014904e-01 | 0.045 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.014904e-01 | 0.045 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 9.014904e-01 | 0.045 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 9.014904e-01 | 0.045 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 9.014904e-01 | 0.045 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.014904e-01 | 0.045 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 9.014904e-01 | 0.045 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 9.014904e-01 | 0.045 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 9.014904e-01 | 0.045 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 9.014904e-01 | 0.045 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.014904e-01 | 0.045 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.014904e-01 | 0.045 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.014904e-01 | 0.045 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.014904e-01 | 0.045 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.014904e-01 | 0.045 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.014904e-01 | 0.045 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.018521e-01 | 0.045 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.033169e-01 | 0.044 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.058308e-01 | 0.043 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.058593e-01 | 0.043 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 9.064808e-01 | 0.043 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 9.064808e-01 | 0.043 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.064808e-01 | 0.043 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.064808e-01 | 0.043 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.064808e-01 | 0.043 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.098102e-01 | 0.041 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.111105e-01 | 0.040 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 9.113248e-01 | 0.040 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 9.117904e-01 | 0.040 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 9.117904e-01 | 0.040 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.117904e-01 | 0.040 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.128500e-01 | 0.040 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.144045e-01 | 0.039 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.158086e-01 | 0.038 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.173357e-01 | 0.037 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.201057e-01 | 0.036 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.201057e-01 | 0.036 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.207372e-01 | 0.036 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.209076e-01 | 0.036 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.210139e-01 | 0.036 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.210139e-01 | 0.036 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.210139e-01 | 0.036 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.210139e-01 | 0.036 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.210139e-01 | 0.036 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.210139e-01 | 0.036 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.216434e-01 | 0.035 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.216434e-01 | 0.035 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.216943e-01 | 0.035 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.216943e-01 | 0.035 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.232033e-01 | 0.035 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.254325e-01 | 0.034 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 9.283961e-01 | 0.032 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.292735e-01 | 0.032 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.292735e-01 | 0.032 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.292735e-01 | 0.032 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.292735e-01 | 0.032 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.292735e-01 | 0.032 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.295385e-01 | 0.032 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.310784e-01 | 0.031 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.316862e-01 | 0.031 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.316862e-01 | 0.031 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.318830e-01 | 0.031 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.336531e-01 | 0.030 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.345531e-01 | 0.029 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.345531e-01 | 0.029 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.345531e-01 | 0.029 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.345531e-01 | 0.029 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.345531e-01 | 0.029 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.363282e-01 | 0.029 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.366698e-01 | 0.028 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 9.366698e-01 | 0.028 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.366698e-01 | 0.028 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.366698e-01 | 0.028 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.366698e-01 | 0.028 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.366698e-01 | 0.028 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.366698e-01 | 0.028 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.366698e-01 | 0.028 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.375422e-01 | 0.028 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.392162e-01 | 0.027 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.402059e-01 | 0.027 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.402059e-01 | 0.027 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.402059e-01 | 0.027 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.402059e-01 | 0.027 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.402059e-01 | 0.027 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.412132e-01 | 0.026 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 9.421249e-01 | 0.026 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.432930e-01 | 0.025 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.432930e-01 | 0.025 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.432930e-01 | 0.025 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.432930e-01 | 0.025 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.432930e-01 | 0.025 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.432930e-01 | 0.025 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.432930e-01 | 0.025 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.432930e-01 | 0.025 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.453926e-01 | 0.024 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.453926e-01 | 0.024 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.453926e-01 | 0.024 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 9.492239e-01 | 0.023 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.492239e-01 | 0.023 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 9.492239e-01 | 0.023 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.492239e-01 | 0.023 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.492239e-01 | 0.023 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.492255e-01 | 0.023 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.494369e-01 | 0.023 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.499066e-01 | 0.022 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.499394e-01 | 0.022 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.501489e-01 | 0.022 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.501489e-01 | 0.022 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.545348e-01 | 0.020 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.545348e-01 | 0.020 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.562239e-01 | 0.019 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.574502e-01 | 0.019 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.585010e-01 | 0.018 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.592905e-01 | 0.018 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.592905e-01 | 0.018 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.592905e-01 | 0.018 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.592905e-01 | 0.018 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.592905e-01 | 0.018 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.605504e-01 | 0.017 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.610431e-01 | 0.017 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.621567e-01 | 0.017 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.621567e-01 | 0.017 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.623220e-01 | 0.017 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.635490e-01 | 0.016 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.635490e-01 | 0.016 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.638943e-01 | 0.016 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.649668e-01 | 0.015 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.655020e-01 | 0.015 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.655020e-01 | 0.015 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.673622e-01 | 0.014 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.694108e-01 | 0.013 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.707768e-01 | 0.013 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.707768e-01 | 0.013 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.707768e-01 | 0.013 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.713592e-01 | 0.013 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.713592e-01 | 0.013 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.722226e-01 | 0.012 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.726602e-01 | 0.012 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.728392e-01 | 0.012 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.738343e-01 | 0.012 | 1 | 1 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.738343e-01 | 0.012 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.738343e-01 | 0.012 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.742856e-01 | 0.011 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.742856e-01 | 0.011 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 9.762041e-01 | 0.010 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.765720e-01 | 0.010 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.765720e-01 | 0.010 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.765720e-01 | 0.010 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.765720e-01 | 0.010 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.772941e-01 | 0.010 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.778131e-01 | 0.010 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.783830e-01 | 0.009 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.790235e-01 | 0.009 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.790235e-01 | 0.009 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.790235e-01 | 0.009 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.792277e-01 | 0.009 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 9.802309e-01 | 0.009 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 9.802309e-01 | 0.009 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 9.802309e-01 | 0.009 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.802309e-01 | 0.009 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.803293e-01 | 0.009 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.803293e-01 | 0.009 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.811828e-01 | 0.008 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.815594e-01 | 0.008 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.815594e-01 | 0.008 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.821050e-01 | 0.008 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.831840e-01 | 0.007 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.843727e-01 | 0.007 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.849439e-01 | 0.007 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.849439e-01 | 0.007 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.851999e-01 | 0.006 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.865197e-01 | 0.006 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.865197e-01 | 0.006 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.873356e-01 | 0.006 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.879307e-01 | 0.005 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.883600e-01 | 0.005 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.891940e-01 | 0.005 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.891940e-01 | 0.005 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.891940e-01 | 0.005 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.891940e-01 | 0.005 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.892119e-01 | 0.005 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.895679e-01 | 0.005 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.897582e-01 | 0.004 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.897582e-01 | 0.004 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.897582e-01 | 0.004 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.899303e-01 | 0.004 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.908045e-01 | 0.004 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.908045e-01 | 0.004 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.913380e-01 | 0.004 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.915505e-01 | 0.004 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.915505e-01 | 0.004 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.919232e-01 | 0.004 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.920044e-01 | 0.003 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.922449e-01 | 0.003 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.922449e-01 | 0.003 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.922449e-01 | 0.003 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.922449e-01 | 0.003 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.922631e-01 | 0.003 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.925483e-01 | 0.003 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.925483e-01 | 0.003 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.930568e-01 | 0.003 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.930568e-01 | 0.003 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.934173e-01 | 0.003 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.935318e-01 | 0.003 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.937838e-01 | 0.003 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.940693e-01 | 0.003 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.944347e-01 | 0.002 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.944347e-01 | 0.002 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.948779e-01 | 0.002 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.948779e-01 | 0.002 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.953744e-01 | 0.002 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.957872e-01 | 0.002 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.958532e-01 | 0.002 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.960065e-01 | 0.002 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.964247e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.967992e-01 | 0.001 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.967992e-01 | 0.001 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.968367e-01 | 0.001 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.969588e-01 | 0.001 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.972558e-01 | 0.001 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.972558e-01 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.973882e-01 | 0.001 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.976654e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.976654e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.978853e-01 | 0.001 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.978950e-01 | 0.001 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.980210e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.981594e-01 | 0.001 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.983523e-01 | 0.001 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.984297e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.984297e-01 | 0.001 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.984297e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.985249e-01 | 0.001 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.985249e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.987453e-01 | 0.001 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.987985e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.989413e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.990527e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.991520e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.992195e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.992409e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.993917e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.993917e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.993989e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.994555e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.995126e-01 | 0.000 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.996010e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.996094e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.996504e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.996652e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.997340e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.997470e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.997493e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.997767e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.997779e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.998559e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.998635e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.998694e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.998710e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.998710e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.998712e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.998803e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.998967e-01 | 0.000 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.999259e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999259e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999261e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.999337e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999473e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999547e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999590e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999611e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999619e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999653e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999660e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999731e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999731e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999778e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999839e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999888e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999919e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999928e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999942e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999942e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999948e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999962e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999973e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999973e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999976e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999985e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999986e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999988e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999991e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999994e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999994e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999998e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999998e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999999e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999999e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999999e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |